Primary Site >> Pancreatic Cancer

Gene >> EPHB2

Journal: Oncogene. 1999 Apr 22;18(16):2579-88.
Title: A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice.
Author: Weisz, B|Giehl, K|Gana-Weisz, M|Egozi, Y|Ben-Baruch, G|Marciano, D|Gierschik, P|Kloog, Y
PMID: 10353601
Journal: Int J Oncol. 1999 Aug;15(2):271-9.
Title: Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression.
Author: Yip-Schneider, M T|Lin, A|Barnard, D|Sweeney, C J|Marshall, M S
PMID: 10402237
Journal: J Gastroenterol. 2000;35(1):1-9.
Title: Stress kinases and heat shock proteins in the pancreas: possible roles in normal function and disease.
Author: Schafer, C|Williams, J A
PMID: 10632533
Journal: Biochem Biophys Res Commun. 2000 Mar 24;269(3):704-8.
Title: Neurotensin-mediated activation of MAPK pathways and AP-1 binding in the human pancreatic cancer cell line, MIA PaCa-2.
Author: Ehlers, R A|Zhang, Y|Hellmich, M R|Evers, B M
PMID: 10720480
Journal: Oncogene. 2000 Sep 14;19(39):4531-41.
Title: TGFbeta1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation.
Author: Giehl, K|Seidel, B|Gierschik, P|Adler, G|Menke, A
PMID: 11002426
Journal: Genes Dev. 2001 Feb 1;15(3):286-93.
Title: A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease.
Author: Wagner, M|Greten, F R|Weber, C K|Koschnick, S|Mattfeldt, T|Deppert, W|Kern, H|Adler, G|Schmid, R M
PMID: 11159909
Journal: Biochem Biophys Res Commun. 2001 Feb 2;280(4):992-7.
Title: Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2.
Author: Yip-Schneider, M T|Lin, A|Marshall, M S
PMID: 11162624
Journal: Biochem Biophys Res Commun. 2001 Mar 30;282(2):447-53.
Title: MEK/ERK-mediated proliferation is negatively regulated by P38 map kinase in the human pancreatic cancer cell line, PANC-1.
Author: Ding, X Z|Adrian, T E
PMID: 11401480
Journal: Biochem Biophys Res Commun. 2001 Jul 13;285(2):207-16.
Title: cAMP protection of pancreatic cancer cells against apoptosis induced by ERK inhibition.
Author: Boucher, M J|Duchesne, C|Laine, J|Morisset, J|Rivard, N
PMID: 11444827
Journal: Gastroenterology. 2001 Sep;121(3):657-67.
Title: Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines.
Author: Weber, C K|Sommer, G|Michl, P|Fensterer, H|Weimer, M|Gansauge, F|Leder, G|Adler, G|Gress, T M
PMID: 11522750
Journal: Pancreas. 2001 Oct;23(3):236-45.
Title: Integrin-mediated differentiation of a pancreatic carcinoma cell line is independent of FAK or MAPK activation levels.
Author: Stagge, V|Seufferlein, T|Duerschmied, D|Menke, A|Adler, G|Beil, M
PMID: 11590318
Journal: Int J Cancer. 2001 Dec 1;94(5):630-6.
Title: 12-lipoxygenase metabolite 12(S)-HETE stimulates human pancreatic cancer cell proliferation via protein tyrosine phosphorylation and ERK activation.
Author: Ding, X Z|Tong, W G|Adrian, T E
PMID: 11745456
Journal: Anticancer Res. 2002 Mar-Apr;22(2A):559-64.
Title: Irofulven (6-hydroxymethylacylfulvene, MGI 114)-induced apoptosis in human pancreatic cancer cells is mediated by ERK and JNK kinases.
Author: Wang, Weixin|Waters, Stephen J|MacDonald, John R|Roth, Caleb|Shentu, Shujun|Freeman, James|Von Hoff, Daniel D|Miller, Alexander R
PMID: 12014623
Journal: FASEB J. 2002 Jul;16(9):975-82.
Title: Heterotopic implantation alters the regulation of apoptosis and the cell cycle and generates a new metastatic site in a human pancreatic tumor xenograft model.
Author: Farre, Lourdes|Casanova, Isolda|Guerrero, Silvia|Trias, Manuel|Capella, Gabriel|Mangues, Ramon
PMID: 12087058
Journal: Oncogene. 2002 Aug 29;21(38):5923-8.
Title: Dominant negative MEKK1 inhibits survival of pancreatic cancer cells.
Author: Hirano, Tatsuya|Shino, Yuji|Saito, Takeshi|Komoda, Fumitake|Okutomi, Yoshiyuki|Takeda, Akiko|Ishihara, Takeshi|Yamaguchi, Taketo|Saisho, Hiromitsu|Shirasawa, Hiroshi
PMID: 12185592
Journal: Int J Gastrointest Cancer. 2002;31(1-3):15-21.
Title: Novel protein kinases in pancreatic cell growth and cancer.
Author: Seufferlein, Thomas
PMID: 12622411
Journal: Int J Cancer. 2003 Jul 1;105(4):454-8.
Title: Leucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosis.
Author: Nagasaki, Koichi|Schem, Christian|von Kaisenberg, Constantin|Biallek, Marco|Rosel, Frank|Jonat, Walter|Maass, Nicolai
PMID: 12712434
Journal: Cancer Res. 2003 May 15;63(10):2379-87.
Title: Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
Author: Guha, Sushovan|Lunn, J Adrian|Santiskulvong, Chintda|Rozengurt, Enrique
PMID: 12750255
Journal: Am J Pathol. 2003 Jun;162(6):1807-15.
Title: Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer.
Author: Furukawa, Toru|Sunamura, Makoto|Motoi, Fuyuhiko|Matsuno, Seiki|Horii, Akira
PMID: 12759238
Journal: Br J Cancer. 2003 Jun 16;88(12):1971-8.
Title: Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro.
Author: Tassone, P|Tagliaferri, P|Viscomi, C|Palmieri, C|Caraglia, M|D'Alessandro, A|Galea, E|Goel, A|Abbruzzese, A|Boland, C R|Venuta, S
PMID: 12799645
Journal: J Cell Sci. 2003 Sep 15;116(Pt 18):3835-46. Epub 2003 Aug 5.
Title: Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK.
Author: Stahle, Martina|Veit, Christine|Bachfischer, Ulla|Schierling, Karina|Skripczynski, Bettina|Hall, Alan|Gierschik, Peter|Giehl, Klaudia
PMID: 12902401
Journal: Cancer. 2003 Aug 15;98(4):720-9.
Title: Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinoma.
Author: Parikh, Alexander A|Liu, Wen Biao|Fan, Fan|Stoeltzing, Oliver|Reinmuth, Niels|Bruns, Christiane J|Bucana, Corazon D|Evans, Douglas B|Ellis, Lee M
PMID: 12910515
Journal: Semin Oncol. 2003 Oct;30(5 Suppl 16):105-16.
Title: CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK).
Author: Allen, Lee F|Sebolt-Leopold, Judith|Meyer, Mark B
PMID: 14613031
Journal: Mol Cancer. 2003 Nov 5;2:37.
Title: p8 inhibits the growth of human pancreatic cancer cells and its expression is induced through pathways involved in growth inhibition and repressed by factors promoting cell growth.
Author: Malicet, Cedric|Lesavre, Nathalie|Vasseur, Sophie|Iovanna, Juan L
PMID: 14613582
Journal: Oncology. 2003;65(4):285-94.
Title: Multiple signal pathways are involved in the mitogenic effect of 5(S)-HETE in human pancreatic cancer.
Author: Ding, Xian-Zhong|Tong, Wei-Gang|Adrian, Thomas E
PMID: 14707447
Journal: Cancer Res Treat. 2003 Jun;35(3):207-12.
Title: Invasion-Metastasis by Hepatocyte Growth Factor/c-Met Signaling Concomitant with Induction of Urokinase Plasminogen Activator in Human Pancreatic Cancer: Role as Therapeutic Target.
Author: Lee, Kyung Hee|Hyun, Myung Soo|Kim, Jae Ryong
PMID: 26680937
Journal: Genes Chromosomes Cancer. 2004 Mar;39(3):224-35.
Title: Expression profiling of the influence of RAS mutants on the TGFB1-induced phenotype of the pancreatic cancer cell line PANC-1.
Author: Fensterer, Heiko|Giehl, Klaudia|Buchholz, Malte|Ellenrieder, Volker|Buck, Anita|Kestler, Hans A|Adler, Guido|Gierschik, Peter|Gress, Thomas M
PMID: 14732924
Journal: Biochem Biophys Res Commun. 2004 Mar 26;316(1):71-7.
Title: Involvement of p38 mitogen-activated protein kinase in gemcitabine-induced apoptosis in human pancreatic cancer cells.
Author: Habiro, Atsuya|Tanno, Satoshi|Koizumi, Kazuya|Izawa, Tsutomu|Nakano, Yasuhiro|Osanai, Manabu|Mizukami, Yusuke|Okumura, Toshikatsu|Kohgo, Yutaka
PMID: 15003513
Journal: Pancreas. 2004 Mar;28(2):153-9.
Title: Activation and role of MAP kinases in 15d-PGJ2-induced apoptosis in the human pancreatic cancer cell line MIA PaCa-2.
Author: Hashimoto, Koji|Farrow, Buckminster J|Evers, B Mark
PMID: 15028947
Journal: Clin Cancer Res. 2004 Apr 1;10(7):2299-306.
Title: Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine.
Author: Yokoi, Kenji|Fidler, Isaiah J
PMID: 15073105
Journal: Gastroenterology. 2004 Aug;127(2):607-20.
Title: KLF11 mediates a critical mechanism in TGF-beta signaling that is inactivated by Erk-MAPK in pancreatic cancer cells.
Author: Ellenrieder, Volker|Buck, Anita|Harth, Ana|Jungert, Kerstin|Buchholz, Malte|Adler, Guido|Urrutia, Raul|Gress, Thomas M
PMID: 15300592
Journal: Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S69-77.
Title: Molecular targeting therapy for pancreatic cancer.
Author: Xiong, Henry Q
PMID: 15316751
Journal: Cancer Res. 2005 Apr 1;65(7):2861-71.
Title: Farnesyl transferase inhibitor (R115777)-induced inhibition of STAT3(Tyr705) phosphorylation in human pancreatic cancer cell lines require extracellular signal-regulated kinases.
Author: Venkatasubbarao, Kolaparthi|Choudary, Ahsan|Freeman, James W
PMID: 15805288
Journal: Mol Cancer. 2005 Jun 21;4(1):21.
Title: Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1.
Author: Lin, Min|DiVito, Melinda M|Merajver, Sofia D|Boyanapalli, Madanamohan|van Golen, Kenneth L
PMID: 15969750
Journal: Biochem Biophys Res Commun. 2005 Sep 30;335(3):949-56.
Title: LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways.
Author: Tong, Wei-Gang|Ding, Xian-Zhong|Talamonti, Mark S|Bell, Richard H|Adrian, Thomas E
PMID: 16105664
Journal: J Clin Pathol. 2005 Dec;58(12):1242-8.
Title: Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway.
Author: Tan, X|Egami, H|Abe, M|Nozawa, F|Hirota, M|Ogawa, M
PMID: 16311341
Journal: Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G729-36.
Title: Galectin-1 induces chemokine production and proliferation in pancreatic stellate cells.
Author: Masamune, Atsushi|Satoh, Masahiro|Hirabayashi, Jun|Kasai, Kenichi|Satoh, Kennichi|Shimosegawa, Tooru
PMID: 16373424
Journal: Am J Pathol. 2006 Mar;168(3):962-72.
Title: Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.
Author: Trevino, Jose G|Summy, Justin M|Lesslie, Donald P|Parikh, Nila U|Hong, David S|Lee, Francis Y|Donato, Nicholas J|Abbruzzese, James L|Baker, Cheryl H|Gallick, Gary E
PMID: 16507911
Journal: Int J Oncol. 2006 Jul;29(1):33-40.
Title: MUC5AC mucin gene regulation in pancreatic cancer cells.
Author: Kato, Shingo|Hokari, Ryota|Crawley, Suzanne|Gum, James|Ahn, Dae-Ho|Kim, Jong-Woo|Kwon, Sung-Won|Miura, Soichiro|Basbaum, Carol B|Kim, Young S
PMID: 16773182
Journal: Ann Surg Oncol. 2006 Jul;13(7):933-9. Epub 2006 May 22.
Title: Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma.
Author: Chadha, Krishdeep S|Khoury, Thaer|Yu, Jihnhee|Black, Jennifer D|Gibbs, John F|Kuvshinoff, Boris W|Tan, Dongfeng|Brattain, Michael G|Javle, Milind M
PMID: 16788754
Journal: World J Gastroenterol. 2006 Jul 28;12(28):4498-503.
Title: Mechanism for Src activation by the CCK2 receptor: Patho-physiological functions of this receptor in pancreas.
Author: Ferrand, Audrey|Vatinel, Sebastien|Kowalski-Chauvel, Aline|Bertrand, Claudine|Escrieut, Chantal|Fourmy, Daniel|Dufresne, Marlene|Seva, Catherine
PMID: 16874861
Journal: Oncol Rep. 2006 Oct;16(4):907-13.
Title: Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells.
Author: Qiu, Lihua|Zhou, Changlin|Sun, Yun|Di, Wen|Scheffler, Erica|Healey, Sarah|Wanebo, Harold|Kouttab, Nicola|Chu, Wenming|Wan, Yinsheng
PMID: 16969513
Journal: Int J Gastrointest Cancer. 2006;37(4):110-9.
Title: Characterization of the CXCR4 signaling in pancreatic cancer cells.
Author: Billadeau, Daniel D|Chatterjee, Subrha|Bramati, Patricia|Sreekumar, Raghavakaimal|Shah, Vijay|Hedin, Karen|Urrutia, Raul
PMID: 18175225
Journal: Cancer Lett. 2007 May 8;249(2):242-8.
Title: BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas.
Author: Schonleben, Frank|Qiu, Wanglong|Bruckman, Karl C|Ciau, Nancy T|Li, Xiaojun|Lauerman, Margaret H|Frucht, Harold|Chabot, John A|Allendorf, John D|Remotti, Helen E|Su, Gloria H
PMID: 17097223
Journal: Cancer. 2007 Mar 15;109(6):1030-9.
Title: Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target.
Author: Camp, E Ramsay|Yang, Anthony|Gray, Mike J|Fan, Fan|Hamilton, Stanley R|Evans, Douglas B|Hooper, Andrea T|Pereira, Daniel S|Hicklin, Daniel J|Ellis, Lee M
PMID: 17311308
Journal: Cancer Biol Ther. 2007 Mar;6(3):367-76. Epub 2007 Mar 13.
Title: Basic transcription factor 3 (BTF3) regulates transcription of tumor-associated genes in pancreatic cancer cells.
Author: Kusumawidjaja, Grace|Kayed, Hany|Giese, Nathalia|Bauer, Andrea|Erkan, Mert|Giese, Thomas|Hoheise, Jorg D|Friess, Helmut|Kleeff, Jorg
PMID: 17312387
Journal: Ann Surg Oncol. 2007 Jul;14(7):2150-8. Epub 2007 Apr 24.
Title: Pancreatic cancer epidermal growth factor receptor (EGFR) intron 1 polymorphism influences postoperative patient survival and in vitro erlotinib response.
Author: Tzeng, Ching-Wei D|Frolov, Andrey|Frolova, Natalya|Jhala, Nirag C|Howard, J Harrison|Vickers, Selwyn M|Buchsbaum, Donald J|Heslin, Martin J|Arnoletti, J Pablo
PMID: 17453292
Journal: Front Biosci. 2007 Sep 1;12:5039-51.
Title: Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer.
Author: Shankar, Sharmila|Suthakar, Ganapathy|Srivastava, Rakesh K
PMID: 17569628
Journal: Cancer Lett. 2007 Oct 8;255(2):241-54. Epub 2007 Jun 21.
Title: Flesh and blood: the story of Vav1, a gene that signals in hematopoietic cells but can be transforming in human malignancies.
Author: Katzav, Shulamit
PMID: 17590270
Journal: Carcinogenesis. 2007 Nov;28(11):2321-7. Epub 2007 Jul 17.
Title: RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells.
Author: Chow, Jimmy Y C|Quach, Khai T|Cabrera, Betty L|Cabral, Jennifer A|Beck, Stayce E|Carethers, John M
PMID: 17638924
Journal: Cell Oncol. 2007;29(4):315-26.
Title: Neurotensin is a versatile modulator of in vitro human pancreatic ductal adenocarcinoma cell (PDAC) migration.
Author: Mijatovic, Tatjana|Gailly, Philippe|Mathieu, Veronique|De Neve, Nancy|Yeaton, Paul|Kiss, Robert|Decaestecker, Christine
PMID: 17641415
Journal: Cancer Res. 2007 Aug 1;67(15):7266-74.
Title: Antiapoptotic effects of progastrin on pancreatic cancer cells are mediated by sustained activation of nuclear factor-{kappa}B.
Author: Rengifo-Cam, William|Umar, Shahid|Sarkar, Shubhashish|Singh, Pomila
PMID: 17671195
Journal: Int J Oncol. 2007 Oct;31(4):693-703.
Title: Expression of connective tissue growth factor in pancreatic cancer cell lines.
Author: Kwon, Sungwon|Munroe, Xander|Crawley, Suzanne C|Lee, Hwa Young|Spong, Suzanne|Bradham, Douglass|Gum, James R Jr|Sleisenger, Marvin H|Kim, Young S
PMID: 17786299
Journal: Ann Surg Oncol. 2007 Dec;14(12):3527-33.
Title: Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer.
Author: Javle, M M|Gibbs, J F|Iwata, K K|Pak, Y|Rutledge, P|Yu, J|Black, J D|Tan, D|Khoury, T
PMID: 17879119
Journal: Cancer Res. 2007 Oct 15;67(20):9704-12.
Title: Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit.
Author: Takehara, Akio|Hosokawa, Masayo|Eguchi, Hidetoshi|Ohigashi, Hiroaki|Ishikawa, Osamu|Nakamura, Yusuke|Nakagawa, Hidewaki
PMID: 17942900
Journal: J Surg Res. 2007 Nov;143(1):20-6.
Title: EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients.
Author: Tzeng, Ching-Wei D|Frolov, Andrey|Frolova, Natalya|Jhala, Nirag C|Howard, J Harrison|Vickers, Selwyn M|Buchsbaum, Donald J|Heslin, Martin J|Arnoletti, J Pablo
PMID: 17950068
Journal: Cancer Lett. 2007 Dec 18;258(2):291-300.
Title: Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system.
Author: Stoeltzing, Oliver|Liu, Wenbiao|Fan, Fan|Wagner, Christine|Stengel, Kathrin|Somcio, Ray J|Reinmuth, Niels|Parikh, Alexander A|Hicklin, Daniel J|Ellis, Lee M
PMID: 17950526
Journal: Clin Cancer Res. 2007 Nov 1;13(21):6459-68.
Title: Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotop
Author: Lang, Sven A|Moser, Christian|Gaumann, Andreas|Klein, Dagmar|Glockzin, Gabriel|Popp, Felix C|Dahlke, Marc H|Piso, Pompiliu|Schlitt, Hans J|Geissler, Edward K|Stoeltzing, Oliver
PMID: 17975158
Journal: J Cell Commun Signal. 2007 Sep;1(2):85-90.
Title: Analysis of CCN2 promoter activity in PANC-1 cells: regulation by ras/MEK/ERK.
Author: Pickles, Melissa|Leask, Andrew
PMID: 18481199
Journal: Front Biosci. 2008 Jan 1;13:440-52.
Title: EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.
Author: Shankar, Sharmila|Ganapathy, Suthakar|Hingorani, Sunil R|Srivastava, Rakesh K
PMID: 17981559
Journal: Cancer. 2008 Feb 15;112(4):767-78.
Title: GABA B receptor is a novel drug target for pancreatic cancer.
Author: Schuller, Hildegard M|Al-Wadei, Hussein A N|Majidi, Mourad
PMID: 18098271
Journal: BMC Cancer. 2008 Feb 6;8:43.
Title: Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis.
Author: Pham, Nhu-An|Schwock, Joerg|Iakovlev, Vladimir|Pond, Greg|Hedley, David W|Tsao, Ming-Sound
PMID: 18254976
Journal:
Title: Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer.
Author:
PMID: 18307536
Journal: Ann Clin Lab Sci. 2008 Winter;38(1):47-56.
Title: Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase.
Author: Adler, Victor|Bowne, Wilbur|Michl, Josef|Sookraj, Kelley A|Ikram, Kamran|Pestka, Sidney|Izotova, Lara|Zenilman, Michael|Friedman, Fred K|Qu, Yongxia|Pincus, Matthew R
PMID: 18316782
Journal: Langenbecks Arch Surg. 2008 May;393(3):289-96.
Title: PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas.
Author: Schonleben, Frank|Qiu, Wanglong|Remotti, Helen E|Hohenberger, Werner|Su, Gloria H
PMID: 18343945
Journal: Blood. 2008 May 15;111(10):5054-63.
Title: Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3.
Author: Chang, Yung-Chi|Chen, Tse-Ching|Lee, Chun-Ting|Yang, Chih-Ya|Wang, Hsei-Wei|Wang, Chao-Ching|Hsieh, Shie-Liang
PMID: 18349319
Journal: Methods Enzymol. 2008;439:451-65.
Title: Ras-driven transformation of human nestin-positive pancreatic epithelial cells.
Author: Campbell, Paul M|Lee, Kwang M|Ouellette, Michel M|Kim, Hong Jin|Groehler, Angela L|Khazak, Vladimir|Der, Channing J
PMID: 18374182
Journal: Curr Med Chem. 2008;15(10):978-90.
Title: ANTI-ADHESION evolves to a promising therapeutic concept in oncology.
Author: Schmidmaier, R|Baumann, P
PMID: 18393855
Journal: Eur J Cancer. 2008 Jul;44(11):1577-86.
Title: Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis.
Author: Moser, Christian|Schachtschneider, Philipp|Lang, Sven A|Gaumann, Andreas|Mori, Akira|Zimmermann, Johann|Schlitt, Hans J|Geissler, Edward K|Stoeltzing, Oliver
PMID: 18445520
Journal: Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):873-9.
Title: SU11248 (sunitinib) sensitizes pancreatic cancer to the cytotoxic effects of ionizing radiation.
Author: Cuneo, Kyle C|Geng, Ling|Fu, Allie|Orton, Darren|Hallahan, Dennis E|Chakravarthy, Anuradha Bapsi
PMID: 18514780
Journal: Am J Physiol Cell Physiol. 2008 Aug;295(2):C394-405.
Title: Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.
Author: Bose, Chhanda|Udupa, Kodetthoor B
PMID: 18550701
Journal: BMC Cancer. 2008 Oct 10;8:294.
Title: Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis.
Author: Shi, Yan|Sahu, Ravi P|Srivastava, Sanjay K
PMID: 18847491
Journal: Mol Cancer Ther. 2008 Nov;7(11):3509-18.
Title: Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes.
Author: Lang, Sven A|Schachtschneider, Philipp|Moser, Christian|Mori, Akira|Hackl, Christina|Gaumann, Andreas|Batt, David|Schlitt, Hans J|Geissler, Edward K|Stoeltzing, Oliver
PMID: 19001434
Journal: Expert Rev Gastroenterol Hepatol. 2008 Oct;2(5):673-96.
Title: New treatment options for advanced pancreatic cancer.
Author: Middleton, Gary|Ghaneh, Paula|Costello, Eithne|Greenhalf, William|Neoptolemos, John P
PMID: 19072345
Journal: Cancer Lett. 2009 Jan 18;273(2):292-9.
Title: Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling.
Author: Zhou, Hui|Huang, Liqun|Sun, Yu|Rigas, Basil
PMID: 18805632
Journal: J Cell Commun Signal. 2009 Jun;3(2):159-60.
Title: Death of a tumor: targeting CCN in pancreatic cancer.
Author: Leask, Andrew
PMID: 19267221
Journal: Biochem Biophys Res Commun. 2009 Mar 13;380(3):614-9.
Title: Troglitazone increases expression of E-cadherin and claudin 4 in human pancreatic cancer cells.
Author: Kumei, Shima|Motomura, Wataru|Yoshizaki, Takayuki|Takakusaki, Kaoru|Okumura, Toshikatsu
PMID: 19285010
Journal: J Cell Physiol. 2009 Jul;220(1):214-21.
Title: Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
Author: Ulivi, Paola|Arienti, Chiara|Amadori, Dino|Fabbri, Francesco|Carloni, Silvia|Tesei, Anna|Vannini, Ivan|Silvestrini, Rosella|Zoli, Wainer
PMID: 19288493
Journal: Int J Biochem Cell Biol. 2009 Aug-Sep;41(8-9):1731-8.
Title: Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
Author: Xue, Aiqun|Xue, Meilang|Jackson, Christopher|Smith, Ross C
PMID: 19433314
Journal: J Cancer Res Clin Oncol. 2009 Dec;135(12):1655-63.
Title: Depleting MEKK1 expression inhibits the ability of invasion and migration of human pancreatic cancer cells.
Author: Su, Fuqin|Li, Hongyan|Yan, Chaoqi|Jia, Baoqing|Zhang, Yi|Chen, Xiaoguang
PMID: 19513748
Journal: Anticancer Agents Med Chem. 2009 Oct;9(8):877-81.
Title: A novel strategy for advanced pancreatic cancer - progression of molecular targeting therapy.
Author: Osada, Shinji|Yoshida, Kazuhiro
PMID: 19538163
Journal: Carcinogenesis. 2009 Oct;30(10):1744-53.
Title: Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells.
Author: Sahu, Ravi P|Zhang, Ruifen|Batra, Sanjay|Shi, Yan|Srivastava, Sanjay K
PMID: 19549704
Journal: Yao Xue Xue Bao. 2009 May;44(5):456-61.
Title: [Effect of icogenin on and its mechanism in anti-metastasis of pancreatic cancer BxPC3 cells].
Author: Su, Fu-qin|Li, Hong-yan|Zhang, Yi|Hou, Shu-jie|Lei, Ping-sheng|Chen, Xiao-guang
PMID: 19618718
Journal: Mol Cancer Res. 2009 Aug;7(8):1390-8.
Title: Up-regulation of Kruppel-like factor 5 in pancreatic cancer is promoted by interleukin-1beta signaling and hypoxia-inducible factor-1alpha.
Author: Mori, Akira|Moser, Christian|Lang, Sven A|Hackl, Christina|Gottfried, Eva|Kreutz, Marina|Schlitt, Hans J|Geissler, Edward K|Stoeltzing, Oliver
PMID: 19671674
Journal: Cancer Biol Ther. 2009 Oct;8(20):1893-901. Epub 2009 Oct 6.
Title: Effects of combined inhibition of MEK and mTOR on downstream signaling and tumor growth in pancreatic cancer xenograft models.
Author: Chang, Qing|Chen, Eric|Hedley, David W
PMID: 20009539
Journal: Zhonghua Zhong Liu Za Zhi. 2009 Oct;31(10):732-7.
Title: [Over-expression of caveolin-1 inhibits proliferation and invasion of pancreatic carcinoma cells in vitro].
Author: Han, Fei|Zhu, Hong-guang
PMID: 20021823
Journal: Pancreas. 2010 Jan;39(1):81-7.
Title: Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways.
Author: Shen, Xiaoming|Artinyan, Avo|Jackson, Desmond|Thomas, Ryan M|Lowy, Andrew M|Kim, Joseph
PMID: 19820417
Journal: Pancreas. 2010 Apr;39(3):332-9.
Title: Loss of 15-hydroxyprostaglandin dehydrogenase increases prostaglandin E2 in pancreatic tumors.
Author: Pham, Hung|Chen, Monica|Li, Aihua|King, Jonathan|Angst, Eliane|Dawson, David W|Park, Jenny|Reber, Howard A|Hines, O Joe|Eibl, Guido
PMID: 19820419
Journal: J Surg Res. 2010 Mar;159(1):443-50.
Title: Caveolin-1 regulating the invasion and expression of matrix metalloproteinase (MMPs) in pancreatic carcinoma cells.
Author: Han, Fei|Zhu, Hong-Guang
PMID: 20031158
Journal: Oncogene. 2010 May 27;29(21):3146-52.
Title: Activation of EGFR by proteasome inhibition requires HB-EGF in pancreatic cancer cells.
Author: Sloss, C M|Wang, F|Palladino, M A|Cusack, J C Jr
PMID: 20208558
Journal: J Cell Physiol. 2010 Jul;224(1):112-9.
Title: Sorafenib combined vitamin K induces apoptosis in human pancreatic cancer cell lines through RAF/MEK/ERK and c-Jun NH2-terminal kinase pathways.
Author: Wei, Gang|Wang, Meifang|Carr, Brian I
PMID: 20301194
Journal: Cancer Sci. 2010 May;101(5):1226-33.
Title: Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2/M cell-cycle arrest and apoptosis.
Author: Li, Wei|Xie, Li|Chen, Zheng|Zhu, Yi|Sun, Yujie|Miao, Yi|Xu, Zekuan|Han, Xiao
PMID: 20331621
Journal: World J Gastroenterol. 2010 Apr 28;16(16):1970-8.
Title: Molecular determinants of the antitumor effects of trichostatin A in pancreatic cancer cells.
Author: Emonds, Elisabeth|Fitzner, Brit|Jaster, Robert
PMID: 20419833
Journal: Curr Cancer Drug Targets. 2010 Sep;10(6):600-10.
Title: In vitro and in vivo antitumor efficacy of docetaxel and sorafenib combination in human pancreatic cancer cells.
Author: Ulivi, P|Arienti, C|Zoli, W|Scarsella, M|Carloni, S|Fabbri, F|Tesei, A|Chiadini, E|Orlandi, A|Passeri, D|Zupi, G|Milandri, C|Silvestrini, R|Amadori, D|Leonetti, C
PMID: 20491617
Journal: Ann Surg Oncol. 2010 Oct;17(10):2619-27.
Title: Higher expression of the heterogeneous nuclear ribonucleoprotein k in melanoma.
Author: Wen, Fushi|Shen, Alex|Shanas, Renee|Bhattacharyya, Achyut|Lian, Fangru|Hostetter, Galen|Shi, Jiaqi
PMID: 20499280
Journal: Oncogene. 2010 Sep 16;29(37):5146-58.
Title: AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-beta-mediated ERK signaling.
Author: Kong, B|Michalski, C W|Hong, X|Valkovskaya, N|Rieder, S|Abiatari, I|Streit, S|Erkan, M|Esposito, I|Friess, H|Kleeff, J
PMID: 20581862
Journal: BMC Cancer. 2010 Jul 14;10:368.
Title: Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies.
Author: Javle, Milind M|Shroff, Rachna T|Xiong, Henry|Varadhachary, Gauri A|Fogelman, David|Reddy, Shrikanth A|Davis, Darren|Zhang, Yujian|Wolff, Robert A|Abbruzzese, James L
PMID: 20630061
Journal: Gynecol Oncol. 2010 Oct;119(1):146-50.
Title: Infrequent methylation of the DUSP6 phosphatase in endometrial cancer.
Author: Chiappinelli, Katherine B|Rimel, B J|Massad, L Stewart|Goodfellow, Paul J
PMID: 20638106
Journal: J Mol Signal. 2010 Jul 19;5:10.
Title: Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer.
Author: Roy, Sanjit K|Srivastava, Rakesh K|Shankar, Sharmila
PMID: 20642839
Journal: Mol Pharm. 2010 Oct 4;7(5):1576-84.
Title: MEK inhibition potentiates the activity of Hsp90 inhibitor 17-AAG against pancreatic cancer cells.
Author: Zhang, Tao|Li, Yanyan|Zhu, Zhenkun|Gu, Mancang|Newman, Bryan|Sun, Duxin
PMID: 20669973
Journal: Chemotherapy. 2010;56(4):303-12.
Title: Synergistic cytotoxicity and molecular interaction on drug targets of sorafenib and gemcitabine in human pancreas cancer cells.
Author: Ricciardi, Simona|Mey, Valentina|Nannizzi, Sara|Pasqualetti, Giuseppe|Crea, Francesco|Del Tacca, Mario|Danesi, Romano
PMID: 20714148
Journal: J Cell Biochem. 2010 Dec 1;111(5):1160-8.
Title: Lysyl oxidase propeptide sensitizes pancreatic and breast cancer cells to doxorubicin-induced apoptosis.
Author: Min, Chengyin|Zhao, Yingshe|Romagnoli, Mathilde|Trackman, Philip C|Sonenshein, Gail E|Kirsch, Kathrin H
PMID: 20717927
Journal: Cancer Sci. 2010 Nov;101(11):2351-60.
Title: Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer.
Author: Yotsumoto, Fusanori|Fukami, Tatsuya|Yagi, Hiroshi|Funakoshi, Akihiro|Yoshizato, Toshiyuki|Kuroki, Masahide|Miyamoto, Shingo
PMID: 20726858
Journal: PLoS One. 2010 Sep 8;5(9):e12653.
Title: Mutational profiling of kinases in human tumours of pancreatic origin identifies candidate cancer genes in ductal and ampulla of vater carcinomas.
Author: Corbo, Vincenzo|Ritelli, Rossana|Barbi, Stefano|Funel, Niccola|Campani, Daniela|Bardelli, Alberto|Scarpa, Aldo
PMID: 20838624
Journal: Mol Cancer. 2010 Sep 21;9:253.
Title: Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway.
Author: Cubas, Rafael|Zhang, Sheng|Li, Min|Chen, Changyi|Yao, Qizhi
PMID: 20858281
Journal: Cancer Biol Ther. 2010 Nov 15;10(10):1056-66.
Title: The induction of S100p expression by the Prostaglandin E(2) (PGE(2))/EP4 receptor signaling pathway in colon cancer cells.
Author: Chandramouli, Anupama|Mercado-Pimentel, Melania E|Hutchinson, Anthony|Gibadulinova, Adriana|Olson, Erik R|Dickinson, Sally|Shanas, Renee|Davenport, Jennifer|Owens, Janae|Bhattacharyya, Achyut K|Regan, John W|Pastorekova, Silvia|Arumugam, Thiruvengadam|Log
PMID: 20890108
Journal: BMC Cancer. 2010 Sep 28;10:515.
Title: Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts.
Author: Chang, Qing|Chapman, Mark S|Miner, Jeffrey N|Hedley, David W
PMID: 20920162
Journal: Gut. 2010 Nov;59(11):1535-44.
Title: PRSS3 promotes tumour growth and metastasis of human pancreatic cancer.
Author: Jiang, Guozhong|Cao, Fengyu|Ren, Guoping|Gao, Dongling|Bhakta, Vipul|Zhang, Yunhan|Cao, Hua|Dong, Ziming|Zang, Weidong|Zhang, Shuijun|Wong, Han Hsi|Hiley, Crispin|Crnogorac-Jurcevic, Tatjana|Lemoine, Nick R|Wang, Yaohe
PMID: 20947888
Journal: J Mol Signal. 2010 Nov 2;5:18.
Title: TLN-4601 suppresses growth and induces apoptosis of pancreatic carcinoma cells through inhibition of Ras-ERK MAPK signaling.
Author: Campbell, Paul M|Boufaied, Nadia|Fiordalisi, James J|Cox, Adrienne D|Falardeau, Pierre|Der, Channing J|Gourdeau, Henriette
PMID: 21044336
Journal: Br J Cancer. 2010 Nov 23;103(11):1671-9.
Title: CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy.
Author: Singh, S|Srivastava, S K|Bhardwaj, A|Owen, L B|Singh, A P
PMID: 21045835
Journal: Cancer Chemother Pharmacol. 2011 Aug;68(2):477-87.
Title: Cytotoxic responses to N-(4-hydroxyphenyl)retinamide in human pancreatic cancer cells.
Author: Messner, Maria C|Cabot, Myles C
PMID: 21072519
Journal: Exp Mol Med. 2011 Feb 28;43(2):82-90.
Title: Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the expression of beta-catenin, leading to a rapid proliferation of pancreatic cells.
Author: Cho, Il-Rae|Koh, Sang Seok|Min, Hye-Jin|Kim, Su Jin|Lee, Yangsoon|Park, Eun-Hee|Ratakorn, Srisuttee|Jhun, Byung Hak|Oh, Sangtaek|Johnston, Randal N|Chung, Young-Hwa
PMID: 21196815
Journal: Biochem Biophys Res Commun. 2011 Feb 18;405(3):377-81.
Title: Anti-MUC1 antibody inhibits EGF receptor signaling in cancer cells.
Author: Hisatsune, Akinori|Nakayama, Hideki|Kawasaki, Mitsuru|Horie, Ichiro|Miyata, Takeshi|Isohama, Yoichiro|Kim, Kwang Chul|Katsuki, Hiroshi
PMID: 21219855
Journal: Clin Cancer Res. 2011 Feb 1;17(3):483-93.
Title: Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth.
Author: Nagaraj, Nagathihalli S|Washington, M Kay|Merchant, Nipun B
PMID: 21266529
Journal: J Biol Chem. 2011 Mar 25;286(12):10495-504.
Title: Pancreatic cancer cells respond to type I collagen by inducing snail expression to promote membrane type 1 matrix metalloproteinase-dependent collagen invasion.
Author: Shields, Mario A|Dangi-Garimella, Surabhi|Krantz, Seth B|Bentrem, David J|Munshi, Hidayatullah G
PMID: 21288898
Journal: Biomed Pharmacother. 2011 Mar;65(2):123-31.
Title: Promoted cancer growth by stimulating cell proliferation and decreasing apoptosis using a lentivirus-based EphB2 RNAi in pancreatic carcinoma CFPAC-1 cells.
Author: Hua, Yong-qiang|Ouyang, Hua-qiang|Chen, Zhen|Meng, Zhi-qiang|Luo, Jian-min|Lin, Jun-hua|Zhou, Zhen-hua|Chen, Hao|Wang, Kun|Liu, Lu-ming
PMID: 21292437
Journal: J Mol Med (Berl). 2011 Sep;89(9):877-89.
Title: Autophagy suppression promotes apoptotic cell death in response to inhibition of the PI3K-mTOR pathway in pancreatic adenocarcinoma.
Author: Mirzoeva, Olga K|Hann, Byron|Hom, Yun K|Debnath, Jayanta|Aftab, Dana|Shokat, Kevan|Korn, W Michael
PMID: 21678117
Journal: Free Radic Biol Med. 2011 Sep 15;51(6):1164-74.
Title: Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway.
Author: Shin-Kang, Sonyo|Ramsauer, Victoria P|Lightner, Janet|Chakraborty, Kanishka|Stone, William|Campbell, Sharon|Reddy, Shrikanth A G|Krishnan, Koyamangalath
PMID: 21723941
Journal: Cancer Biol Ther. 2011 Oct 1;12(7):574-85. Epub 2011 Oct 1.
Title: Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer.
Author: Jiang, Yixing|DiVittore, Nicole A|Kaiser, James M|Shanmugavelandy, Sriram S|Fritz, Jennifer L|Heakal, Yasser|Tagaram, Hephzibah Rani S|Cheng, Hua|Cabot, Myles C|Staveley-O'Carroll, Kevin F|Tran, Melissa A|Fox, Todd E|Barth, Brian M|Kester, Mark
PMID: 21795855
Journal: PLoS One. 2011;6(9):e25166.
Title: Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors.
Author: Roy, Sanjit K|Chen, Qinghe|Fu, Junsheng|Shankar, Sharmila|Srivastava, Rakesh K
PMID: 21980390
Journal: World J Gastroenterol. 2011 Sep 7;17(33):3810-7.
Title: Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro.
Author: Gu, Yu-Mei|Ma, Yi-Hui|Zhao, Wu-Gan|Chen, Jie
PMID: 21987623
Journal: PLoS One. 2011;6(10):e26815.
Title: DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance.
Author: Danilov, Alexey V|Neupane, Divas|Nagaraja, Archana Sidalaghatta|Feofanova, Elena V|Humphries, Leigh Ann|DiRenzo, James|Korc, Murray
PMID: 22053213
Journal: Anticancer Res. 2011 Nov;31(11):3747-56.
Title: Mechanisms underlying gemcitabine resistance in pancreatic cancer and sensitisation by the iMiD lenalidomide.
Author: Fryer, Rosemary A|Barlett, Blake|Galustian, Christine|Dalgleish, Angus G
PMID: 22110196
Journal: Cancer Epidemiol. 2012 Apr;36(2):206-11.
Title: Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer.
Author: Dong, Xiaoqun|Li, Yanan|Tang, Hongwei|Chang, Ping|Hess, Kenneth R|Abbruzzese, James L|Li, Donghui
PMID: 21852217
Journal: J Gastroenterol. 2012 Feb;47(2):203-13.
Title: Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression.
Author: Mohri, Dai|Asaoka, Yoshinari|Ijichi, Hideaki|Miyabayashi, Koji|Kudo, Yotaro|Seto, Motoko|Ohta, Miki|Tada, Motohisa|Tanaka, Yasuo|Ikenoue, Tsuneo|Tateishi, Keisuke|Isayama, Hiroyuki|Kanai, Fumihiko|Fukushima, Noriyoshi|Tada, Minoru|Kawabe, Takao|Omata, Mas
PMID: 22041919
Journal: Carcinogenesis. 2012 Jan;33(1):191-6.
Title: Regulation of pancreatic cancer by neuropsychological stress responses: a novel target for intervention.
Author: Schuller, Hildegard M|Al-Wadei, Hussein A N|Ullah, Mohammad F|Plummer, Howard K 3rd
PMID: 22072614
Journal: Mol Cancer Res. 2012 Feb;10(2):239-49.
Title: Pancreatic cancer cells and normal pancreatic duct epithelial cells express an autocrine catecholamine loop that is activated by nicotinic acetylcholine receptors alpha3, alpha5, and alpha7.
Author: Al-Wadei, Mohammed H|Al-Wadei, Hussein A N|Schuller, Hildegard M
PMID: 22188668
Journal: Ann Surg Oncol. 2012 Aug;19(8):2733-43.
Title: VEGF-A/VEGFR-2 signaling plays an important role for the motility of pancreas cancer cells.
Author: Doi, Yosuke|Yashiro, Masakazu|Yamada, Nobuya|Amano, Ryosuke|Noda, Satoru|Hirakawa, Kosei
PMID: 22207048
Journal: Biochem Biophys Res Commun. 2012 Jan 20;417(3):1074-9.
Title: RAS oncogenic signal upregulates EZH2 in pancreatic cancer.
Author: Fujii, Satoshi|Fukamachi, Katsumi|Tsuda, Hiroyuki|Ito, Kosei|Ito, Yoshiaki|Ochiai, Atsushi
PMID: 22222375
Journal: Mod Pathol. 2012 May;25(5):758-66.
Title: Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma.
Author: Chung, Yeon Tae|Matkowskyj, Kristina A|Li, Haonan|Bai, Han|Zhang, Wanying|Tsao, Ming-Sound|Liao, Jie|Yang, Guang-Yu
PMID: 22222635
Journal: Int J Cancer. 2012 Oct 15;131(8):1951-62.
Title: Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice.
Author: Mohammed, Altaf|Qian, Li|Janakiram, Naveena B|Lightfoot, Stan|Steele, Vernon E|Rao, Chinthalapally V
PMID: 22287227
Journal: Hepatogastroenterology. 2012 Mar-Apr;59(114):584-8.
Title: Beta-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice.
Author: Lin, Xueping|Luo, Kai|Lv, Zhongwei|Huang, Jian
PMID: 22353526
Journal: Bioorg Med Chem. 2012 Apr 15;20(8):2520-6.
Title: Growth inhibition and mechanism of action of p-dodecylaminophenol against refractory human pancreatic cancer and cholangiocarcinoma.
Author: Imai, Masahiko|Takahashi, Noriko
PMID: 22440084
Journal: Mol Cancer. 2012 Apr 26;11:24.
Title: Nicotine, IFN-gamma and retinoic acid mediated induction of MUC4 in pancreatic cancer requires E2F1 and STAT-1 transcription factors and utilize different signaling cascades.
Author: Kunigal, Sateesh|Ponnusamy, Moorthy P|Momi, Navneet|Batra, Surinder K|Chellappan, Srikumar P
PMID: 22537161
Journal: Oncol Rep. 2012 Aug;28(2):519-26.
Title: Combined effects of EGFR and Hedgehog signaling pathway inhibition on the proliferation and apoptosis of pancreatic cancer cells.
Author: Qin, Chang-Fu|Hao, Kun|Tian, Xiao-Dong|Xie, Xue-Hai|Yang, Yin-Mo
PMID: 22581058
Journal: Front Biosci (Landmark Ed). 2012 Jun 1;17:2541-9.
Title: BMP2 induces PANC-1 cell invasion by MMP-2 overexpression through ROS and ERK.
Author: Liu, Jun|Ben, Qi-Wen|Yao, Wei-Yan|Zhang, Jian-Jun|Chen, Da-Fan|He, Xiang-Yi|Li, Lei|Yuan, Yao-Zong
PMID: 22652796
Journal: PLoS One. 2012;7(6):e39684.
Title: Concomitant targeting of EGF receptor, TGF-beta and SRC points to a novel therapeutic approach in pancreatic cancer.
Author: Deharvengt, Sophie|Marmarelis, Melina|Korc, Murray
PMID: 22761868
Journal: Br J Cancer. 2012 Jul 24;107(3):501-7.
Title: Secreted semaphorin 5A suppressed pancreatic tumour burden but increased metastasis and endothelial cell proliferation.
Author: Sadanandam, A|Sidhu, S S|Wullschleger, S|Singh, S|Varney, M L|Yang, C-S|Ashour, A E|Batra, S K|Singh, R K
PMID: 22782341
Journal: Oncol Lett. 2012 Jun;3(6):1207-1212.
Title: Overexpression of the B-type Eph and ephrin genes correlates with progression and pain in human pancreatic cancer.
Author: Lu, Zhenhui|Zhang, Yong|Li, Zhaoyu|Yu, Songning|Zhao, Guozhong|Li, Minghao|Wang, Zuozhen|Wang, Qi|Yang, Yinxue
PMID: 22783419
Journal: Carcinogenesis. 2012 Sep;33(9):1745-53.
Title: Effects of chronic nicotine on the autocrine regulation of pancreatic cancer cells and pancreatic duct epithelial cells by stimulatory and inhibitory neurotransmitters.
Author: Al-Wadei, Mohammed H|Al-Wadei, Hussein A N|Schuller, Hildegard M
PMID: 22791813
Journal: JOP. 2012 Jul 10;13(4):345-8.
Title: Novel agents and new combination treatments on phase I studies on solid tumors and pancreatic cancer.
Author: Strimpakos, Alexios S|Syrigos, Kostas N|Saif, Muhammad W
PMID: 22797386
Journal: Mol Cancer Res. 2012 Dec;10(12):1607-19.
Title: Analysis of mRNA profiles after MEK1/2 inhibition in human pancreatic cancer cell lines reveals pathways involved in drug sensitivity.
Author: Gysin, Stephan|Paquette, Jesse|McMahon, Martin
PMID: 22833572
Journal: PLoS One. 2012;7(8):e42699.
Title: Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling.
Author: Song, Shumei|Ji, Baoan|Ramachandran, Vijaya|Wang, Huamin|Hafley, Margarete|Logsdon, Craig|Bresalier, Robert S
PMID: 22900040
Journal: Anat Rec (Hoboken). 2012 Dec;295(12):2122-8.
Title: Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line.
Author: Xiao, Zhi|Ding, Nianhua|Xiao, Guiqing|Wang, Shouman|Wu, Yuhui|Tang, Lili
PMID: 22907845
Journal: PLoS One. 2012;7(8):e43376.
Title: Celecoxib and GABA cooperatively prevent the progression of pancreatic cancer in vitro and in xenograft models of stress-free and stress-exposed mice.
Author: Al-Wadei, Hussein A N|Al-Wadei, Mohammed H|Ullah, Mohammad F|Schuller, Hildegard M
PMID: 22916251
Journal: Zhonghua Yi Xue Za Zhi. 2012 Jul 10;92(26):1849-53.
Title: [Effects and mechanisms of combined suppression of epidermal growth factor receptor and hedgehog signaling on proliferation in pancreatic cancer cells].
Author: Qin, Chang-fu|Tian, Xiao-dong|Hao, Kun|Yang, Yin-mo
PMID: 22944238
Journal: J Biol Chem. 2012 Nov 9;287(46):39115-24.
Title: CXCL12/CXCR4 protein signaling axis induces sonic hedgehog expression in pancreatic cancer cells via extracellular regulated kinase- and Akt kinase-mediated activation of nuclear factor kappaB: implications for bidirectional tumor-stromal interactions.
Author: Singh, Ajay P|Arora, Sumit|Bhardwaj, Arun|Srivastava, Sanjeev K|Kadakia, Madhavi P|Wang, Bin|Grizzle, William E|Owen, Laurie B|Singh, Seema
PMID: 22995914
Journal: Biochim Biophys Acta. 2012 Dec;1823(12):2120-9.
Title: Novel involvement of leukotriene B(4) receptor 2 through ERK activation by PP2A down-regulation in leukotriene B(4)-induced keratin phosphorylation and reorganization of pancreatic cancer cells.
Author: Park, Mi Kyung|Park, Youngran|Shim, Jaegal|Lee, Hye Ja|Kim, Sanghee|Lee, Chang Hoon
PMID: 23017243
Journal: Oncol Lett. 2012 Oct;4(4):783-791.
Title: MACC1: A potential molecule associated with pancreatic cancer metastasis and chemoresistance.
Author: Wang, Gang|Kang, Mu-Xing|Lu, Wen-Jie|Chen, Ying|Zhang, Bo|Wu, Yu-Lian
PMID: 23205101
Journal: Mol Cell Biochem. 2013 Jan;372(1-2):83-94.
Title: EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin.
Author: Shankar, Sharmila|Marsh, Luke|Srivastava, Rakesh K
PMID: 22971992
Journal: Cancer Lett. 2013 May 1;331(2):250-61.
Title: Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic cancer cells.
Author: Yun, Sun-Mi|Jung, Kyung Hee|Lee, Hyunseung|Son, Mi Kwon|Seo, Ju-Hyeon|Yan, Hong Hua|Park, Byung Hee|Hong, Sungwoo|Hong, Soon-Sun
PMID: 23340175
Journal: PLoS One. 2013;8(2):e52526.
Title: Vitamin E delta-tocotrienol induces p27(Kip1)-dependent cell-cycle arrest in pancreatic cancer cells via an E2F-1-dependent mechanism.
Author: Hodul, Pamela J|Dong, Yanbin|Husain, Kazim|Pimiento, Jose M|Chen, Jiandong|Zhang, Anying|Francois, Rony|Pledger, Warren J|Coppola, Domenico|Sebti, Said M|Chen, Dung-Tsa|Malafa, Mokenge P
PMID: 23393547
Journal: PLoS One. 2013;8(2):e57289.
Title: Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells.
Author: Soares, Heloisa P|Ni, Yang|Kisfalvi, Krisztina|Sinnett-Smith, James|Rozengurt, Enrique
PMID: 23437362
Journal: Pancreas. 2013 Jul;42(5):781-5.
Title: Metformin inhibits the growth of human pancreatic cancer xenografts.
Author: Kisfalvi, Krisztina|Moro, Aune|Sinnett-Smith, James|Eibl, Guido|Rozengurt, Enrique
PMID: 23462329
Journal: J Exp Clin Cancer Res. 2013 Mar 6;32:12.
Title: Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II.
Author: Awasthi, Niranjan|Zhang, Changhua|Hinz, Stefan|Schwarz, Margaret A|Schwarz, Roderich E
PMID: 23497499
Journal: Int J Med Sci. 2013;10(5):634-40.
Title: Proliferation enhanced by NGF-NTRK1 signaling makes pancreatic cancer cells more sensitive to 2DG-induced apoptosis.
Author: Cheng, Yao|Diao, Dong-mei|Zhang, Hao|Song, Yong-Chun|Dang, Cheng-Xue
PMID: 23569426
Journal: Cell Biol Int. 2013 May;37(5):478-84.
Title: Direct TGF-beta1 signaling between activated platelets and pancreatic cancer cells primes cisplatin insensitivity.
Author: Chen, Hongxu|Lan, Xiang|Liu, Menggang|Zhou, Bo|Wang, Baoling|Chen, Ping
PMID: 23584798
Journal: Lab Invest. 2013 Jun;93(6):720-32.
Title: Transforming growth factor-alpha activates pancreatic stellate cells and may be involved in matrix metalloproteinase-1 upregulation.
Author: Tahara, Hiroki|Sato, Ken|Yamazaki, Yuichi|Ohyama, Tatsuya|Horiguchi, Norio|Hashizume, Hiroaki|Kakizaki, Satoru|Takagi, Hitoshi|Ozaki, Iwata|Arai, Hideo|Hirato, Junko|Jesenofsky, Ralf|Masamune, Atsushi|Mori, Masatomo
PMID: 23608755
Journal: PLoS One. 2013 May 8;8(5):e63969.
Title: Low concentrations of metformin selectively inhibit CD133(+) cell proliferation in pancreatic cancer and have anticancer action.
Author: Gou, Shanmiao|Cui, Pengfei|Li, Xiangsheng|Shi, Pengfei|Liu, Tao|Wang, Chunyou
PMID: 23667692
Journal: PLoS One. 2013 Jun 10;8(6):e65403.
Title: Synergism between Hedgehog-GLI and EGFR signaling in Hedgehog-responsive human medulloblastoma cells induces downregulation of canonical Hedgehog-target genes and stabilized expression of GLI1.
Author: Gotschel, Frank|Berg, Daniela|Gruber, Wolfgang|Bender, Christian|Eberl, Markus|Friedel, Myriam|Sonntag, Johanna|Rungeler, Elena|Hache, Hendrik|Wierling, Christoph|Nietfeld, Wilfried|Lehrach, Hans|Frischauf, Annemarie|Schwartz-Albiez, Reinhard|Aberger, Fri
PMID: 23762360
Journal: Biochem Biophys Res Commun. 2013 Aug 2;437(3):433-9.
Title: miR-210 regulates the interaction between pancreatic cancer cells and stellate cells.
Author: Takikawa, Tetsuya|Masamune, Atsushi|Hamada, Shin|Nakano, Eriko|Yoshida, Naoki|Shimosegawa, Tooru
PMID: 23831622
Journal: Oncol Lett. 2013 Jun;5(6):1958-1964.
Title: alpha-Mangostin suppresses lipopolysaccharide-induced invasion by inhibiting matrix metalloproteinase-2/9 and increasing E-cadherin expression through extracellular signal-regulated kinase signaling in pancreatic cancer cells.
Author: Yuan, Jiangtao|Wu, Yaolu|Lu, Guifang
PMID: 23833675
Journal: PLoS One. 2013 Jul 29;8(7):e69992.
Title: Ron knockdown and Ron monoclonal antibody IMC-RON8 sensitize pancreatic cancer to histone deacetylase inhibitors (HDACi).
Author: Zou, Yi|Howell, Gillian M|Humphrey, Lisa E|Wang, Jing|Brattain, Michael G
PMID: 23922886
Journal: Mol Cancer. 2013 Sep 11;12(1):104.
Title: Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer.
Author: Venkatasubbarao, Kolaparthi|Peterson, Lindsay|Zhao, Shujie|Hill, Ping|Cao, Lin|Zhou, Qing|Nawrocki, Steffan T|Freeman, James W
PMID: 24025152
Journal: Bioorg Med Chem. 2013 Nov 1;21(21):6414-26.
Title: Quinazolino linked 4beta-amidopodophyllotoxin conjugates regulate angiogenic pathway and control breast cancer cell proliferation.
Author: Kamal, Ahmed|Tamboli, Jaki R|Ramaiah, M Janaki|Adil, S F|Pushpavalli, S N C V L|Ganesh, Raksha|Sarma, Pranjal|Bhadra, Utpal|Pal-Bhadra, Manika
PMID: 24055291
Journal: Cancer Res. 2013 Oct 15;73(20):6359-74.
Title: Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance.
Author: Zhang, Yaqing|Yan, Wei|Collins, Meredith A|Bednar, Filip|Rakshit, Sabita|Zetter, Bruce R|Stanger, Ben Z|Chung, Ivy|Rhim, Andrew D|di Magliano, Marina Pasca
PMID: 24097820
Journal: J Transl Med. 2013 Dec 14;11:311.
Title: Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC).
Author: Karamitopoulou, Eva|Zlobec, Inti|Gloor, Beat|Kondi-Pafiti, Agathi|Lugli, Alessandro|Perren, Aurel
PMID: 24330423
Journal: PLoS One. 2013 Dec 31;8(12):e85502.
Title: The MEK/ERK pathway promotes NOTCH signalling in pancreatic cancer cells.
Author: Tremblay, Isabelle|Pare, Emanuel|Arsenault, Dominique|Douziech, Melanie|Boucher, Marie-Josee
PMID: 24392017
Journal: Mol Carcinog. 2014 Oct;53(10):787-92.
Title: Up-regulated cten by FGF2 contributes to FGF2-mediated cell migration.
Author: Hung, Shih-Ya|Shih, Yi-Ping|Chen, Michelle|Lo, Su Hao
PMID: 23625726
Journal: Oncogene. 2014 Sep 18;33(38):4664-74.
Title: microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-beta actions.
Author: Ouyang, H|Gore, J|Deitz, S|Korc, M
PMID: 24096486
Journal: Phytomedicine. 2014 Mar 15;21(4):491-6.
Title: Novel synthetic oleanane triterpenoid AMR-MeOAc inhibits K-Ras through ERK, Akt and survivin in pancreatic cancer cells.
Author: Rabi, Thangaiyan|Venkatanarashiman, Mathuram
PMID: 24215674
Journal: J Cell Physiol. 2014 Jul;229(7):887-97.
Title: Overexpression of calreticulin contributes to the development and progression of pancreatic cancer.
Author: Sheng, Weiwei|Chen, Chuanping|Dong, Ming|Zhou, Jianping|Liu, Qingfeng|Dong, Qi|Li, Feng
PMID: 24264800
Journal: Oncol Rep. 2014 Feb;31(2):975-82.
Title: Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK.
Author: Bu, He-Qi|Liu, Dian-Lei|Wei, Wei-Tian|Chen, Liang|Huang, Hai|Li, Ye|Cui, Jun-Hui
PMID: 24297112
Journal: Cancer Res. 2014 Feb 15;74(4):1190-9.
Title: Phosphorylation at Ser-181 of oncogenic KRAS is required for tumor growth.
Author: Barcelo, Carles|Paco, Noelia|Morell, Mireia|Alvarez-Moya, Blanca|Bota-Rabassedas, Neus|Jaumot, Montserrat|Vilardell, Felip|Capella, Gabriel|Agell, Neus
PMID: 24371225
Journal: Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Jan;30(1):23-7.
Title: [Mechanism underlying pancreatic cancer cell resistance to mTOR inhibitor RAD001 via c-Raf/ERK1/2 activation].
Author: Wei, Feng|Zhang, Ping|Qi, Jun|Wang, Meng|Wang, Guangyi
PMID: 24405594
Journal: Cancer Chemother Pharmacol. 2014 Apr;73(4):711-9.
Title: Perifosine inhibits S6K1-Gli1 signaling and enhances gemcitabine-induced anti-pancreatic cancer efficiency.
Author: Xin, Ying|Shen, Xiang-di|Cheng, Long|Hong, De-fei|Chen, Bin
PMID: 24519751
Journal: Mol Cancer. 2014 Feb 25;13:38.
Title: Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma.
Author: Luan, Zhou|He, Ying|Alattar, Mohamed|Chen, Zhishui|He, Fan
PMID: 24568222
Journal: Clin Cancer Res. 2014 May 15;20(10):2793-804.
Title: A pharmacodynamic/pharmacokinetic study of ficlatuzumab in patients with advanced solid tumors and liver metastases.
Author: Tabernero, Josep|Elez, Maria Elena|Herranz, Maria|Rico, Isabel|Prudkin, Ludmila|Andreu, Jordi|Mateos, Jose|Carreras, Maria Josep|Han, May|Gifford, James|Credi, Marc|Yin, Wei|Agarwal, Shefali|Komarnitsky, Philip|Baselga, Jose
PMID: 24634378
Journal: Curr Cancer Drug Targets. 2014;14(4):348-56.
Title: Hyperglycemia regulates TXNIP/TRX/ROS axis via p38 MAPK and ERK pathways in pancreatic cancer.
Author: Li, Wei|Wu, Zheng|Ma, Qingyong|Liu, Jiangbo|Xu, Qinhong|Han, Liang|Duan, Wanxing|Lv, Yunfu|Wang, Fengfei|Reindl, Katie M|Wu, Erxi
PMID: 24720336
Journal: Curr Cancer Drug Targets. 2014;14(5):446-57.
Title: The Activation of beta1-integrin by Type I Collagen Coupling with the Hedgehog Pathway Promotes the Epithelial-Mesenchymal Transition in Pancreatic Cancer.
Author: Duan, Wanxing|Ma, Jiguang|Ma, Qingyong|Xu, Qinhong|Lei, Jianjun|Han, Liang|Li, Xuqi|Wang, Zheng|Wu, Zheng|Lv, Shifang|Ma, Zhenhua|Liu, Mouzhu|Wang, Fengfei|Wu, Erxi
PMID: 24720337
Journal: Oncol Rep. 2014 Jun;31(6):2792-6.
Title: Polyserase-1/TMPRSS9 induces pro-tumor effects in pancreatic cancer cells by activation of pro-uPA.
Author: Fontanil, Tania|Mohamedi, Yamina|Esteban, Manuel M|Obaya, Alvaro J|Cal, Santiago
PMID: 24756697
Journal: Mol Cancer Ther. 2014 Jul;13(7):1758-71.
Title: Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling.
Author: Balic, Anamaria|Sorensen, Morten Draeby|Trabulo, Sara Maria|Sainz, Bruno Jr|Cioffi, Michele|Vieira, Catarina R|Miranda-Lorenzo, Irene|Hidalgo, Manuel|Kleeff, Joerg|Erkan, Mert|Heeschen, Christopher
PMID: 24785258
Journal: PLoS One. 2014 May 1;9(5):e96060.
Title: PTK6 promotes cancer migration and invasion in pancreatic cancer cells dependent on ERK signaling.
Author: Ono, Hiroaki|Basson, Marc D|Ito, Hiromichi
PMID: 24788754
Journal: Int J Oncol. 2014 Jul;45(1):311-21.
Title: HS-104, a PI3K inhibitor, enhances the anticancer efficacy of gemcitabine in pancreatic cancer.
Author: Jung, Kyung Hee|Yan, Hong Hua|Fang, Zhenghuan|Son, Mi Kwon|Lee, Hyunseung|Hong, Sungwoo|Hong, Soon-Sun
PMID: 24819705
Journal: Cell Death Dis. 2014 May 22;5:e1241.
Title: Rasfonin, a novel 2-pyrone derivative, induces ras-mutated Panc-1 pancreatic tumor cell death in nude mice.
Author: Xiao, Z|Li, L|Li, Y|Zhou, W|Cheng, J|Liu, F|Zheng, P|Zhang, Y|Che, Y
PMID: 24853419
Journal: Oncol Lett. 2014 Jul;8(1):17-24.
Title: High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC-1 cells through the EphrinB1-EphB2 pathway.
Author: Hua, Yong-Qiang|Chen, Zhen|Meng, Zhi-Qiang|Chen, Hao|Shen, Jian-Gang|Wang, Kun|Peng, Wang|Shen, Ye-Hua|Liu, Lu-Ming
PMID: 24959213
Journal: Cancer Sci. 2014 Sep;105(9):1212-9.
Title: Inhibition of fibroblast growth factor receptor 2 attenuates proliferation and invasion of pancreatic cancer.
Author: Matsuda, Yoko|Yoshimura, Hisashi|Suzuki, Taeko|Uchida, Eiji|Naito, Zenya|Ishiwata, Toshiyuki
PMID: 24975163
Journal: Neoplasia. 2014 Jul;16(7):562-71.
Title: Co-treatment with panitumumab and trastuzumab augments response to the MEK inhibitor trametinib in a patient-derived xenograft model of pancreatic cancer.
Author: Lindberg, James M|Newhook, Timothy E|Adair, Sara J|Walters, Dustin M|Kim, Alison J|Stelow, Edward B|Parsons, J Thomas|Bauer, Todd W
PMID: 25117978
Journal: Gastroenterology. 2014 Nov;147(5):1119-33.e4.
Title: Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Author: Hermann, Patrick C|Sancho, Patricia|Canamero, Marta|Martinelli, Paola|Madriles, Francesc|Michl, Patrick|Gress, Thomas|de Pascual, Ricardo|Gandia, Luis|Guerra, Carmen|Barbacid, Mariano|Wagner, Martin|Vieira, Catarina R|Aicher, Alexandra|Real, Francisco X|S
PMID: 25127677
Journal: Oncotarget. 2014 Oct 15;5(19):9150-68.
Title: Crizotinib exhibits antitumor activity by targeting ALK signaling not c-MET in pancreatic cancer.
Author: Yan, Hong Hua|Jung, Kyung Hee|Son, Mi Kwon|Fang, Zhenghuan|Kim, Soo Jung|Ryu, Ye-Lim|Kim, Juyoung|Kim, Mi-Hyun|Hong, Soon-Sun
PMID: 25193856
Journal: Sci China Life Sci. 2014 Oct;57(10):1011-7.
Title: Recombinant expression of different mutant K-ras gene in pancreatic cancer Bxpc-3 cells and its effects on chemotherapy sensitivity.
Author: Shao, TengFei|Zheng, YuanTing|Zhao, Bei|Li, Tao|Cheng, KeGuang|Cai, WeiMin
PMID: 25216706
Journal: Oncotarget. 2014 Sep 30;5(18):8778-89.
Title: p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-kappaB pathway.
Author: Tyagi, Nikhil|Bhardwaj, Arun|Singh, Ajay P|McClellan, Steven|Carter, James E|Singh, Seema
PMID: 25238288
Journal: BMC Cancer. 2014 Sep 27;14:725.
Title: Differential modulation of nicotine-induced gemcitabine resistance by GABA receptor agonists in pancreatic cancer cell xenografts and in vitro.
Author: Banerjee, Jheelam|Al-Wadei, Hussein An|Al-Wadei, Mohammed H|Dagnon, Koami|Schuller, Hildegard M
PMID: 25260978
Journal: Cancer Lett. 2014 Dec 28;355(2):273-80.
Title: Knockdown or inhibition of aldo-keto reductase 1B10 inhibits pancreatic carcinoma growth via modulating Kras-E-cadherin pathway.
Author: Zhang, Wanying|Li, Haonan|Yang, Yihe|Liao, Jie|Yang, Guang-Yu
PMID: 25304374
Journal: Curr Mol Med. 2014;14(9):1126-38.
Title: Cholinergic receptors as target for cancer therapy in a systems medicine perspective.
Author: Russo, P|Del Bufalo, A|Milic, M|Salinaro, G|Fini, M|Cesario, A
PMID: 25324001
Journal: Cell Death Dis. 2014 Oct 23;5:e1480.
Title: RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer.
Author: Kang, R|Hou, W|Zhang, Q|Chen, R|Lee, Y J|Bartlett, D L|Lotze, M T|Tang, D|Zeh, H J
PMID: 25341034
Journal: BMC Cancer. 2014 Nov 6;14:814.
Title: Effects of insulin on human pancreatic cancer progression modeled in vitro.
Author: Chan, Michelle T|Lim, Gareth E|Skovso, Sos|Yang, Yu Hsuan Carol|Albrecht, Tobias|Alejandro, Emilyn U|Hoesli, Corinne A|Piret, James M|Warnock, Garth L|Johnson, James D
PMID: 25373319
Journal: Hormones (Athens). 2014 Oct-Dec;13(4):498-508.
Title: Anticancer effects of metformin on neuroendocrine tumor cells in vitro.
Author: Vlotides, George|Tanyeri, Ayse|Spampatti, Matilde|Zitzmann, Kathrin|Chourdakis, Michael|Spttl, Chourdakis|Maurer, Julian|Nolting, Svenja|Goke, Burkhard|Auernhammer, Christoph J
PMID: 25402373
Journal: Acta Histochem. 2014 Oct;116(8):1434-42.
Title: Dynamic distribution of ERK, p38 and JNK during the development of pancreatic ductal adenocarcinoma.
Author: Amsterdam, Abraham|Shpigner, Lotem|Raanan, Calanit|Schreiber, Letizia|Melzer, Ehud|Seger, Rony
PMID: 25440531
Journal: PLoS One. 2014 Dec 10;9(12):e114573.
Title: Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells.
Author: Ming, Ming|Sinnett-Smith, James|Wang, Jia|Soares, Heloisa P|Young, Steven H|Eibl, Guido|Rozengurt, Enrique
PMID: 25493642
Journal: Int J Clin Exp Pathol. 2014 Oct 15;7(11):7536-44. eCollection 2014.
Title: Effect of DAPK1 gene on proliferation, migration, and invasion of carcinoma of pancreas BxPC-3 cell line.
Author: Qin, Yong|Ye, Guan-Xiong|Wu, Cheng-Jun|Wang, Shi|Pan, De-Biao|Jiang, Jin-Yan|Fu, Jing|Xu, Sheng-Qian
PMID: 25550789
Journal: Oncogene. 2015 May 21;34(21):2801-6.
Title: Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey.
Author: Park, J T|Johnson, N|Liu, S|Levesque, M|Wang, Y J|Ho, H|Huso, D|Maitra, A|Parsons, M J|Prescott, J D|Leach, S D
PMID: 25065594
Journal: Tumour Biol. 2015 Feb;36(2):1015-22.
Title: CRKL protein overexpression enhances cell proliferation and invasion in pancreatic cancer.
Author: Fu, Lin|Dong, Qianze|Xie, Chengyao|Wang, Yan|Li, Qingchang
PMID: 25318601
Journal: Biochim Biophys Acta. 2015 Jan;1853(1):157-65.
Title: Glaucarubinone inhibits colorectal cancer growth by suppression of hypoxia-inducible factor 1alpha and beta-catenin via a p-21 activated kinase 1-dependent pathway.
Author: Huynh, Nhi|Beutler, John A|Shulkes, Arthur|Baldwin, Graham S|He, Hong
PMID: 25409929
Journal: Naunyn Schmiedebergs Arch Pharmacol. 2015 Mar;388(3):295-304.
Title: Lupeol inhibits proliferation and induces apoptosis of human pancreatic cancer PCNA-1 cells through AKT/ERK pathways.
Author: Liu, Yan|Bi, Tingting|Wang, Gang|Dai, Wei|Wu, Guoliang|Qian, Liqiang|Gao, Quangen|Shen, Genhai
PMID: 25418891
Journal: Biochem Biophys Res Commun. 2015 Jan 16;456(3):821-6.
Title: The glucosylceramide synthase inhibitor PDMP sensitizes pancreatic cancer cells to MEK/ERK inhibitor AZD-6244.
Author: Wang, Ting|Wei, Jue|Wang, Na|Ma, Jia-Li|Hui, Ping-Ping
PMID: 25498501
Journal: Mol Cancer Ther. 2015 Feb;14(2):407-18.
Title: A preclinical evaluation of SKLB261, a multikinase inhibitor of EGFR/Src/VEGFR2, as a therapeutic agent against pancreatic cancer.
Author: Pan, Youli|Zheng, Mingwu|Zhong, Lei|Yang, Jiao|Zhou, Shu|Qin, Ya|Xiang, Rong|Chen, Yuzong|Yang, Sheng-Yong
PMID: 25519702
Journal: Acta Pharmacol Sin. 2015 Mar;36(3):291-7.
Title: The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer.
Author: Guin, Sunny|Theodorescu, Dan
PMID: 25557115
Journal: Br J Cancer. 2015 Feb 3;112(3):514-22.
Title: Combining clinicopathological predictors and molecular biomarkers in the oncogenic K-RAS/Ki67/HIF-1alpha pathway to predict survival in resectable pancreatic cancer.
Author: Qin, R|Smyrk, T C|Reed, N R|Schmidt, R L|Schnelldorfer, T|Chari, S T|Petersen, G M|Tang, A H
PMID: 25584484
Journal: Oncotarget. 2015 Mar 10;6(7):4829-44.
Title: Inhibition of EP2/EP4 signaling abrogates IGF-1R-mediated cancer cell growth: involvement of protein kinase C-theta activation.
Author: Takahashi, Tetsuyuki|Uehara, Hisanori|Ogawa, Hirohisa|Umemoto, Hitomi|Bando, Yoshimi|Izumi, Keisuke
PMID: 25638159
Journal: IUBMB Life. 2015 Jan;67(1):42-53.
Title: MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreatic cancer.
Author: Guo, Rende|Gu, Jianhua|Zhang, Zhibin|Wang, Yi|Gu, Chuan
PMID: 25646808
Journal: Mol Cancer Ther. 2015 Apr;14(4):1014-23.
Title: Dual PI3K/mTOR Inhibitors Induce Rapid Overactivation of the MEK/ERK Pathway in Human Pancreatic Cancer Cells through Suppression of mTORC2.
Author: Soares, Heloisa P|Ming, Ming|Mellon, Michelle|Young, Steven H|Han, Liang|Sinnet-Smith, James|Rozengurt, Enrique
PMID: 25673820
Journal: Apoptosis. 2015 Jun;20(6):843-57.
Title: Tenascin-C induces resistance to apoptosis in pancreatic cancer cell through activation of ERK/NF-kappaB pathway.
Author: Shi, Meiyan|He, Xiaodan|Wei, Wei|Wang, Juan|Zhang, Ti|Shen, Xiaohong
PMID: 25690319
Journal: Mol Cancer Res. 2015 May;13(5):863-9.
Title: Detection of Tumor Suppressor Genes in Cancer Development by a Novel shRNA-Based Method.
Author: von Burstin, Johannes|Diersch, Sandra|Schneider, Gunter|Reichert, Maximilian|Rustgi, Anil K|Schmid, Roland M
PMID: 25724428
Journal: Cell Res. 2015 May;25(5):561-73.
Title: ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer.
Author: Ji, Shunrong|Qin, Yi|Shi, Si|Liu, Xiangyuan|Hu, Hongli|Zhou, Hu|Gao, Jing|Zhang, Bo|Xu, Wenyan|Liu, Jiang|Liang, Dingkong|Liu, Liang|Liu, Chen|Long, Jiang|Zhou, Haijun|Chiao, Paul J|Xu, Jin|Ni, Quanxing|Gao, Daming|Yu, Xianjun
PMID: 25753158
Journal: Bioorg Med Chem. 2015 Apr 1;23(7):1386-94.
Title: Dual inhibition of allosteric mitogen-activated protein kinase (MEK) and phosphatidylinositol 3-kinase (PI3K) oncogenic targets with a bifunctional inhibitor.
Author: Van Dort, Marcian E|Galban, Stefanie|Wang, Hanxiao|Sebolt-Leopold, Judith|Whitehead, Christopher|Hong, Hao|Rehemtulla, Alnawaz|Ross, Brian D
PMID: 25766633
Journal: Int J Oncol. 2015;46(6):2613-20.
Title: Superoxide dismutase promotes the epithelial-mesenchymal transition of pancreatic cancer cells via activation of the H2O2/ERK/NF-kappaB axis.
Author: Li, Wei|Cao, Lei|Han, Liang|Xu, Qinhong|Ma, Qingyong
PMID: 25825208
Journal: BMC Cancer. 2015 Apr 4;15:223.
Title: Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors.
Author: Urtasun, Nerea|Vidal-Pla, Anna|Perez-Torras, Sandra|Mazo, Adela
PMID: 25886138
Journal: Oncotarget. 2015 Jun 20;6(17):15297-310.
Title: A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion.
Author: Butler, Amanda M|Scotti Buzhardt, Michele L|Erdogan, Eda|Li, Shuhua|Inman, Kristin S|Fields, Alan P|Murray, Nicole R
PMID: 25915428
Journal: Cancer Lett. 2015 Aug 1;364(1):17-24.
Title: LIM-only protein FHL2 critically determines survival and radioresistance of pancreatic cancer cells.
Author: Zienert, Elisa|Eke, Iris|Aust, Daniela|Cordes, Nils
PMID: 25917075
Journal: Oncotarget. 2015 Aug 28;6(25):21085-99.
Title: Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells.
Author: Lakshmanan, Imayavaramban|Seshacharyulu, Parthasarathy|Haridas, Dhanya|Rachagani, Satyanarayana|Gupta, Suprit|Joshi, Suhasini|Guda, Chittibabu|Yan, Ying|Jain, Maneesh|Ganti, Apar K|Ponnusamy, Moorthy P|Batra, Surinder K
PMID: 26035354
Journal: Biochem Biophys Res Commun. 2015 Aug 7;463(4):612-7.
Title: Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer.
Author: Bian, Yong|Yu, Yun|Wang, Shanshan|Li, Lin
PMID: 26043686
Journal: Sci Rep. 2015 Jul 2;5:11836.
Title: Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA.
Author: Shen, Meng|Wu, Meng-Yao|Chen, Long-Pei|Zhi, Qiaoming|Gong, Fei-Ran|Chen, Kai|Li, Dao-Ming|Wu, Yadi|Tao, Min|Li, Wei
PMID: 26135631
Journal: Clin Cancer Res. 2015 Dec 15;21(24):5563-77.
Title: The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy in Pancreatic Cancer Models by Altering Ribonucleotide Reductase Subunit-1 (RRM1).
Author: Vena, Francesca|Li Causi, Eleonora|Rodriguez-Justo, Manuel|Goodstal, Samantha|Hagemann, Thorsten|Hartley, John A|Hochhauser, Daniel
PMID: 26228206
Journal: Adv Biol Regul. 2015 Sep;59:65-81.
Title: Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells.
Author: Fitzgerald, Timothy L|Lertpiriyapong, Kvin|Cocco, Lucio|Martelli, Alberto M|Libra, Massimo|Candido, Saverio|Montalto, Giuseppe|Cervello, Melchiorre|Steelman, Linda|Abrams, Stephen L|McCubrey, James A
PMID: 26257206
Journal: BMC Cancer. 2015 Aug 11;15:581.
Title: Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation.
Author: Yadav, Vikas|Varshney, Pallavi|Sultana, Sarwat|Yadav, Jyoti|Saini, Neeru
PMID: 26260159
Journal: Int J Clin Exp Pathol. 2015 Jun 1;8(6):6724-31. eCollection 2015.
Title: Expression of CD44 in pancreatic cancer and its significance.
Author: Li, Xiao-Ping|Zhang, Xiao-Wei|Zheng, Lei-Zhen|Guo, Wei-Jian
PMID: 26261555
Journal: DNA Cell Biol. 2015 Oct;34(10):610-7.
Title: The Antipancreatic Cancer Activity of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2.
Author: Chen, Bo|Xu, Ming|Zhang, Hui|Xu, Ming-zheng|Wang, Xu-jing|Tang, Qing-he|Tang, Jian-ying
PMID: 26284306
Journal: Oncotarget. 2015 Nov 24;6(37):39521-37.
Title: Novel agents for advanced pancreatic cancer.
Author: Akinleye, Akintunde|Iragavarapu, Chaitanya|Furqan, Muhammad|Cang, Shundong|Liu, Delong
PMID: 26369833
Journal: Sci Rep. 2015 Sep 22;5:14404.
Title: Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling.
Author: Chai, Xinqun|Chu, Hongpeng|Yang, Xuan|Meng, Yuanpu|Shi, Pengfei|Gou, Shanmiao
PMID: 26391180
Journal: Oncol Rep. 2015 Dec;34(6):3304-10.
Title: The flavonoid p-hydroxycinnamic acid exhibits anticancer effects in human pancreatic cancer MIA PaCa-2 cells in vitro: Comparison with gemcitabine.
Author: Yamaguchi, Masayoshi|Murata, Tomiyasu|El-Rayes, Bassel F|Shoji, Mamoru
PMID: 26397991
Journal: Oncotarget. 2015 Oct 13;6(31):31119-33.
Title: Hydrogen peroxide mediates hyperglycemia-induced invasive activity via ERK and p38 MAPK in human pancreatic cancer.
Author: Li, Wei|Ma, Zhenhua|Ma, Jiguang|Li, Xuqi|Xu, Qinhong|Duan, Wanxing|Chen, Xin|Lv, Yunfu|Zhou, Shuang|Wu, Erxi|Ma, Qingyong|Huo, Xiongwei
PMID: 26439801
Journal: Biochim Biophys Acta. 2015 Dec;1849(12):1375-84.
Title: The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-kappaB and RalB signaling pathways.
Author: Vasseur, Romain|Skrypek, Nicolas|Duchene, Belinda|Renaud, Florence|Martinez-Maqueda, Daniel|Vincent, Audrey|Porchet, Nicole|Van Seuningen, Isabelle|Jonckheere, Nicolas
PMID: 26477488
Journal: Hepatobiliary Pancreat Dis Int. 2015 Dec;14(6):642-50.
Title: Trametinib and dactolisib but not regorafenib exert antiproliferative effects on rat pancreatic stellate cells.
Author: Witteck, Laura|Jaster, Robert
PMID: 26663013
Journal: Tumour Biol. 2016 Feb;37(2):2519-26.
Title: Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cells.
Author: Tveteraas, Ingun Heiene|Aasrum, Monica|Brusevold, Ingvild Johnsen|Odegard, John|Christoffersen, Thoralf|Sandnes, Dagny
PMID: 26386720
Journal: Tumour Biol. 2016 Apr;37(4):5117-31.
Title: Integrin beta6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC).
Author: Li, Zequn|Lin, Pengfei|Gao, Chao|Peng, Cheng|Liu, Song|Gao, Huijie|Wang, Ben|Wang, Jiayong|Niu, Jun|Niu, Weibo
PMID: 26547582
Journal: Cancer Res. 2016 Jan 15;76(2):418-28.
Title: Neuropilin-2 Regulates Endosome Maturation and EGFR Trafficking to Support Cancer Cell Pathobiology.
Author: Dutta, Samikshan|Roy, Sohini|Polavaram, Navatha S|Stanton, Marissa J|Zhang, Heyu|Bhola, Tanvi|Honscheid, Pia|Donohue, Terrence M Jr|Band, Hamid|Batra, Surinder K|Muders, Michael H|Datta, Kaustubh
PMID: 26560516
Journal: Cancer Lett. 2016 Feb 28;371(2):187-93.
Title: Inhibition of mutant KrasG12D-initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t-CUPM.
Author: Liao, Jie|Hwang, Sung Hee|Li, Haonan|Yang, Yihe|Yang, Jun|Wecksler, Aaron T|Liu, Jun-Yan|Hammock, Bruce D|Yang, Guang-Yu
PMID: 26683769
Journal: Cancer Cell. 2016 Jan 11;29(1):75-89.
Title: Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression.
Author: Hayes, Tikvah K|Neel, Nicole F|Hu, Chaoxin|Gautam, Prson|Chenard, Melissa|Long, Brian|Aziz, Meraj|Kassner, Michelle|Bryant, Kirsten L|Pierobon, Mariaelena|Marayati, Raoud|Kher, Swapnil|George, Samuel D|Xu, Mai|Wang-Gillam, Andrea|Samatar, Ahmed A|Maitra,
PMID: 26725216
Journal: Cell Cycle. 2016;15(3):381-93.
Title: Inflammatory stimuli promote growth and invasion of pancreatic cancer cells through NF-kappaB pathway dependent repression of PP2Ac.
Author: Tao, Min|Liu, Lu|Shen, Meng|Zhi, Qiaoming|Gong, Fei-Ran|Zhou, Binhua P|Wu, Yadi|Liu, Haiyan|Chen, Kai|Shen, Bairong|Wu, Meng-Yao|Shou, Liu-Mei|Li, Wei
PMID: 26761431
Journal: Cancer Biol Ther. 2016;17(2):188-98.
Title: Hypoxia regulates ABCG2 activity through the activivation of ERK1/2/HIF-1alpha and contributes to chemoresistance in pancreatic cancer cells.
Author: He, Xiaodan|Wang, Juan|Wei, Wei|Shi, Meiyan|Xin, Beibei|Zhang, Ti|Shen, Xiaohong
PMID: 26785721
Journal: Sci Rep. 2016 Jan 25;6:19819.
Title: Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition.
Author: Subramani, Ramadevi|Gonzalez, Elizabeth|Arumugam, Arunkumar|Nandy, Sushmita|Gonzalez, Viviana|Medel, Joshua|Camacho, Fernando|Ortega, Andrew|Bonkoungou, Sandrine|Narayan, Mahesh|Dwivedi, Alok kumar|Lakshmanaswamy, Rajkumar
PMID: 26804739
Journal: Ann Surg Oncol. 2016 Jun;23(6):1993-2000.
Title: Adjuvant Trametinib Delays the Outgrowth of Occult Pancreatic Cancer in a Mouse Model of Patient-Derived Liver Metastasis.
Author: Newhook, Timothy E|Lindberg, James M|Adair, Sara J|Kim, Alison J|Stelow, Edward B|Rahma, Osama E|Parsons, J Thomas|Bauer, Todd W
PMID: 26847682
Journal: Cancer Res. 2016 Apr 15;76(8):2243-2253.
Title: PR55alpha Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling.
Author: Hein, Ashley L|Seshacharyulu, Parthasarathy|Rachagani, Satyanarayana|Sheinin, Yuri M|Ouellette, Michel M|Ponnusamy, Moorthy P|Mumby, Marc C|Batra, Surinder K|Yan, Ying
PMID: 26893480
Journal: Cancer Res. 2016 May 1;76(9):2612-25.
Title: Genomic Loss of DUSP4 Contributes to the Progression of Intraepithelial Neoplasm of Pancreas to Invasive Carcinoma.
Author: Hijiya, Naoki|Tsukamoto, Yoshiyuki|Nakada, Chisato|Tung Nguyen, Lam|Kai, Tomoki|Matsuura, Keiko|Shibata, Kohei|Inomata, Masafumi|Uchida, Tomohisa|Tokunaga, Akinori|Amada, Kohei|Shirao, Kuniaki|Yamada, Yasunari|Mori, Hiromu|Takeuchi, Ichiro|Seto, Masao|Aok
PMID: 26941286
Journal: Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G1124-37.
Title: Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer.
Author: Vorvis, Christina|Hatziapostolou, Maria|Mahurkar-Joshi, Swapna|Koutsioumpa, Marina|Williams, Jennifer|Donahue, Timothy R|Poultsides, George A|Eibl, Guido|Iliopoulos, Dimitrios
PMID: 27151939
Journal: Nat Genet. 2016 Jul;48(7):747-57.
Title: Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation.
Author: Zheng, Jian|Huang, Xudong|Tan, Wen|Yu, Dianke|Du, Zhongli|Chang, Jiang|Wei, Lixuan|Han, Yaling|Wang, Chengfeng|Che, Xu|Zhou, Yifeng|Miao, Xiaoping|Jiang, Guoliang|Yu, Xianjun|Yang, Xianghong|Cao, Guangwen|Zuo, Chaohui|Li, Zhaoshen|Wang, Chunyou|Cheung, Si
PMID: 27213290
Journal: Oncotarget. 2016 Jun 28;7(26):39996-40011.
Title: Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis.
Author: Hanson, Ryan L|Brown, Roger B|Steele, Maria M|Grandgenett, Paul M|Grunkemeyer, James A|Hollingsworth, Michael A
PMID: 27220889
Journal: Oncotarget. 2016 Jun 28;7(26):40148-40159.
Title: Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling.
Author: Liu, Yang|Li, Fan|Gao, Feng|Xing, Lingxi|Qin, Peng|Liang, Xingxin|Zhang, Jiajie|Qiao, Xiaohui|Lin, Lizhou|Zhao, Qian|Du, Lianfang
PMID: 27223086
Journal: Biochem Biophys Res Commun. 2016 Aug 5;476(4):260-266.
Title: The preclinical evaluation of TIC10/ONC201 as an anti-pancreatic cancer agent.
Author: Zhang, Qiangbo|Wang, Hong|Ran, Lin|Zhang, Zongli|Jiang, Runde
PMID: 27233611
Journal: Int J Oncol. 2016 Aug;49(2):735-43.
Title: Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways.
Author: Cao, Lei|Chen, Xin|Xiao, Xue|Ma, Qingyong|Li, Wei
PMID: 27278736
Journal: Toxicon. 2016 Sep 1;119:203-17.
Title: Isolation, characterization and screening of the in vitro cytotoxic activity of a novel L-amino acid oxidase (LAAOcdt) from Crotalus durissus terrificus venom on human cancer cell lines.
Author: Teixeira, Tuila Leveghim|Oliveira Silva, Viviane Aline|da Cunha, Daniel Batista|Polettini, Flavia Lino|Thomaz, Camila Daniele|Pianca, Ariana Aparecida|Zambom, Fabiana Leticia|da Silva Leitao Mazzi, Denise Pimenta|Reis, Rui Manuel|Mazzi, Mauricio Ventura
PMID: 27317870
Journal: Cancer Lett. 2016 Sep 28;380(1):87-97.
Title: Inhibition of the NF-kappaB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
Author: Lu, Yun-Xin|Ju, Huai-Qiang|Wang, Feng|Chen, Le-Zong|Wu, Qi-Nian|Sheng, Hui|Mo, Hai-Yu|Pan, Zhi-Zhong|Xie, Dan|Kang, Tie-Bang|Chen, Gong|Yun, Jing-Ping|Zeng, Zhao-Lei|Xu, Rui-Hua
PMID: 27322737
Journal: Cancer Lett. 2016 Sep 28;380(1):98-105.
Title: The hepatitis B virus X protein promotes pancreatic cancer through modulation of the PI3K/AKT signaling pathway.
Author: Chen, Yiwen|Bai, Xueli|Zhang, Qi|Wen, Liang|Su, Wei|Fu, Qihan|Sun, Xu|Lou, Yu|Yang, Jiaqi|Zhang, Jingying|Chen, Qi|Wang, Jianxin|Liang, Tingbo
PMID: 27339327
Journal: Pharmacol Res. 2016 Sep;111:757-766.
Title: Selective GPR55 antagonism reduces chemoresistance in cancer cells.
Author: Singh, Nagendra S|Bernier, Michel|Wainer, Irving W
PMID: 27423937
Journal: Cell Biol Int. 2016 Oct;40(10):1050-61.
Title: Extracellular vesicles from malignant effusions induce tumor cell migration: inhibitory effect of LMWH tinzaparin.
Author: Gamperl, Hans|Plattfaut, Corinna|Freund, Annika|Quecke, Tabea|Theophil, Friederike|Gieseler, Frank
PMID: 27435911
Journal: Oncotarget. 2016 Sep 20;7(38):61469-61484.
Title: Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Author: Yamamoto, Keisuke|Tateishi, Keisuke|Kudo, Yotaro|Hoshikawa, Mayumi|Tanaka, Mariko|Nakatsuka, Takuma|Fujiwara, Hiroaki|Miyabayashi, Koji|Takahashi, Ryota|Tanaka, Yasuo|Ijichi, Hideaki|Nakai, Yousuke|Isayama, Hiroyuki|Morishita, Yasuyuki|Aoki, Taku|Sakamoto
PMID: 27528027
Journal: Pharmacol Ther. 2016 Dec;168:29-42.
Title: KRAS-related proteins in pancreatic cancer.
Author: Mann, Karen M|Ying, Haoqiang|Juan, Joseph|Jenkins, Nancy A|Copeland, Neal G
PMID: 27595930
Journal: Sci Rep. 2016 Sep 9;6:32809.
Title: Paeoniflorin Potentiates the Inhibitory Effects of Erlotinib in Pancreatic Cancer Cell Lines by Reducing ErbB3 Phosphorylation.
Author: Hao, Jian|Yang, Xue|Ding, Xiu-Li|Guo, Lei-Ming|Zhu, Cui-Hong|Ji, Wei|Zhou, Tong|Wu, Xiong-Zhi
PMID: 27609096
Journal: J Biol Inorg Chem. 2016 Dec;21(8):919-929.
Title: Bis(acetylacetonato)-oxidovanadium(IV) and sodium metavanadate inhibit cell proliferation via ROS-induced sustained MAPK/ERK activation but with elevated AKT activity in human pancreatic cancer AsPC-1 cells.
Author: Wu, Jing-Xuan|Hong, Yi-Hua|Yang, Xiao-Gai
PMID: 27614430
Journal: Oncotarget. 2016 Oct 18;7(42):68412-68433.
Title: Dual oxidase 2 and pancreatic adenocarcinoma: IFN-gamma-mediated dual oxidase 2 overexpression results in H2O2-induced, ERK-associated up-regulation of HIF-1alpha and VEGF-A.
Author: Wu, Yongzhong|Meitzler, Jennifer L|Antony, Smitha|Juhasz, Agnes|Lu, Jiamo|Jiang, Guojian|Liu, Han|Hollingshead, Melinda|Haines, Diana C|Butcher, Donna|Panter, Michaela S|Roy, Krishnendu|Doroshow, James H
PMID: 27637085
Journal: Pancreatology. 2016 Nov - Dec;16(6):1005-1014.
Title: Nerve growth factor regulates CD133 function to promote tumor cell migration and invasion via activating ERK1/2 signaling in pancreatic cancer.
Author: Xin, Beibei|He, Xiaodan|Wang, Juan|Cai, Jun|Wei, Wei|Zhang, Ti|Shen, Xiaohong
PMID: 27654574
Journal: Oncol Rep. 2016 Nov;36(5):2861-2867.
Title: Melatonin induces cell apoptosis in Mia PaCa-2 cells via the suppression of nuclear factor-kappaB and activation of ERK and JNK: A novel therapeutic implication for pancreatic cancer.
Author: Li, Weimin|Wu, Jiansheng|Li, Zhiyin|Zhou, Zhibo|Zheng, Chao|Lin, Le|Tan, Binbin|Huang, Min|Fan, Mengdi
PMID: 27666165
Journal: Exp Mol Med. 2016 Sep 30;48(9):e261.
Title: CTHRC1 promotes angiogenesis by recruiting Tie2-expressing monocytes to pancreatic tumors.
Author: Lee, Jaemin|Song, Jinhoi|Kwon, Eun-Soo|Jo, Seongyea|Kang, Min Kyung|Kim, Yeon Jeong|Hwang, Yeonsil|Bae, Hosung|Kang, Tae Heung|Chang, Suhwan|Cho, Hee Jun|Kim, Song Cheol|Kim, Seokho|Koh, Sang Seok
PMID: 27686285
Journal: Oncol Rep. 2016 Dec;36(6):3413-3420.
Title: c-Fos/ERK promotes the progression from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma.
Author: You, Lei|Ren, Xiaoxia|Du, Yongxing|Zhao, Wenjing|Cui, Ming|Chen, Ge|Zhao, Yupei
PMID: 27748943
Journal: Oncotarget. 2016 Nov 22;7(47):77916-77925.
Title: Pseudomonas aeruginosa-mannose-sensitive hemagglutinin inhibits pancreatic cancer cell proliferation and induces apoptosis via the EGFR pathway and caspase signaling.
Author: Cheng, Xi|Wang, Bingrui|Jin, Zhijian|Ma, Ding|Yang, Weiping|Zhao, Ren|Jing, Xiaoqian|Shen, Baiyong|Peng, Chenghong|Qiu, Weihua
PMID: 27788491
Journal: Clin Cancer Res. 2017 Jan 15;23(2):489-502.
Title: IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells.
Author: McMichael, Elizabeth L|Jaime-Ramirez, Alena Cristina|Guenterberg, Kristan D|Luedke, Eric|Atwal, Lakhvir S|Campbell, Amanda R|Hu, Zhiwei|Tatum, Armika S|Kondadasula, Sri Vidya|Mo, Xiaokui|Tridandapani, Susheela|Bloomston, Mark|Ellison, E Christopher|Willia
PMID: 27435400
Journal: Semin Cancer Biol. 2017 Feb;42:70-80.
Title: Smyd3-associated regulatory pathways in cancer.
Author: Giakountis, Antonis|Moulos, Panagiotis|Sarris, Michalis E|Hatzis, Pantelis|Talianidis, Iannis
PMID: 27554136
Journal: Mol Carcinog. 2017 Apr;56(4):1344-1360.
Title: Adenylyl cyclase 3/adenylyl cyclase-associated protein 1 (CAP1) complex mediates the anti-migratory effect of forskolin in pancreatic cancer cells.
Author: Quinn, Sierra N|Graves, Sarai H|Dains-McGahee, Clayton|Friedman, Emilee M|Hassan, Humma|Witkowski, Piotr|Sabbatini, Maria E
PMID: 27891679
Journal: Cancer Lett. 2017 Mar 1;388:303-311.
Title: ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancer.
Author: Liang, Chen|Qin, Yi|Zhang, Bo|Ji, Shunrong|Shi, Si|Xu, Wenyan|Liu, Jiang|Xiang, Jinfeng|Liang, Dingkong|Hu, Qiangsheng|Ni, Quanxing|Yu, Xianjun|Xu, Jin
PMID: 28025100
Journal: PLoS One. 2017 Jan 4;12(1):e0169335.
Title: The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways.
Author: Youns, Msmall a, Cyrillichmoud|Abdel Halim Hegazy, Wael
PMID: 28052097
Journal: Cancer Cell Int. 2017 Jan 10;17:12.
Title: HNRNPA2B1 regulates the epithelial-mesenchymal transition in pancreatic cancer cells through the ERK/snail signalling pathway.
Author: Dai, Shengjie|Zhang, Jie|Huang, Shihao|Lou, Bin|Fang, Binbo|Ye, Tingting|Huang, Xince|Chen, Bicheng|Zhou, Mengtao
PMID: 28077929
Journal: Mol Cancer Res. 2017 Feb;15(2):201-212.
Title: Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma.
Author: Liang, Chen|Qin, Yi|Zhang, Bo|Ji, Shunrong|Shi, Si|Xu, Wenyan|Liu, Jiang|Xiang, Jinfeng|Liang, Dingkong|Hu, Qiangsheng|Ni, Quanxing|Xu, Jin|Yu, Xianjun
PMID: 28108627
Journal: PLoS One. 2017 Jan 23;12(1):e0170390.
Title: The G Protein-Coupled Receptor RAI3 Is an Independent Prognostic Factor for Pancreatic Cancer Survival and Regulates Proliferation via STAT3 Phosphorylation.
Author: Jahny, Elisabeth|Yang, Hai|Liu, Bin|Jahnke, Beatrix|Lademann, Franziska|Knosel, Thomas|Rummele, Petra|Grutzmann, Robert|Aust, Daniela E|Pilarsky, Christian|Denz, Axel
PMID: 28114355
Journal: Cancer Sci. 2017 May;108(5):1049-1057.
Title: Novel small molecule inhibiting CDCP1-PKCdelta pathway reduces tumor metastasis and proliferation.
Author: Nakashima, Katsuhiko|Uekita, Takamasa|Yano, Shigenobu|Kikuchi, Jun-Ichi|Nakanishi, Ruri|Sakamoto, Nozomi|Fukumoto, Keisuke|Nomoto, Akihiro|Kawamoto, Keisuke|Shibahara, Takashi|Yamaguchi, Hideki|Sakai, Ryuichi
PMID: 28256037
Journal: Mol Carcinog. 2017 Aug;56(8):1884-1895.
Title: Loss of desmoglein 2 promotes tumorigenic behavior in pancreatic cancer cells.
Author: Hutz, Katharina|Zeiler, Julian|Sachs, Lena|Ormanns, Steffen|Spindler, Volker
PMID: 28277619
Journal: Int J Oncol. 2017 May;50(5):1792-1800.
Title: A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism.
Author: Liu, Wensheng|Zhang, Bo|Hu, Qiangsheng|Qin, Yi|Xu, Wenyan|Shi, Si|Liang, Chen|Meng, Qingcai|Xiang, Jinfeng|Liang, Dingkong|Ji, Shunrong|Liu, Jiang|Hu, Pengfei|Liu, Liang|Liu, Chen|Long, Jiang|Ni, Quanxing|Yu, Xianjun|Xu, Jin
PMID: 28350132
Journal: PLoS One. 2017 May 5;12(5):e0176844.
Title: LSL-KrasG12D; LSL-Trp53R172H/+; Ink4flox/+; Ptf1/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer.
Author: Ma, Lixiang|Saiyin, Hexige
PMID: 28475592
Journal: Cancers (Basel). 2017 May 17;9(5). pii: cancers9050052.
Title: Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways.
Author: Wee, Ping|Wang, Zhixiang
PMID: 28513565
Journal: DNA Cell Biol. 2017 Aug;36(8):619-626.
Title: miR-144-3p Induces Cell Cycle Arrest and Apoptosis in Pancreatic Cancer Cells by Targeting Proline-Rich Protein 11 Expression via the Mitogen-Activated Protein Kinase Signaling Pathway.
Author: Li, Jian|Sun, Peisheng|Yue, Zhongyi|Zhang, Dezhong|You, Kun|Wang, Jianguo
PMID: 28574724
Journal: Oncotarget. 2017 Jul 4;8(27):44295-44311.
Title: Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancer.
Author: Ning, Changwen|Liang, Min|Liu, Shuang|Wang, Guan|Edwards, Holly|Xia, Yang|Polin, Lisa|Dyson, Gregory|Taub, Jeffrey W|Mohammad, Ramzi M|Azmi, Asfar S|Zhao, Lijing|Ge, Yubin
PMID: 28574828
Journal: Br J Cancer. 2017 Jul 11;117(2):245-255.
Title: KIF15 promotes pancreatic cancer proliferation via the MEK-ERK signalling pathway.
Author: Wang, Jie|Guo, Xingjun|Xie, Chencheng|Jiang, Jianxin
PMID: 28595260
Journal: Mol Cancer Ther. 2017 Sep;16(9):1729-1738.
Title: Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma.
Author: Sahu, Nisebita|Chan, Emily|Chu, Felix|Pham, Thinh|Koeppen, Hartmut|Forrest, William|Merchant, Mark|Settleman, Jeff
PMID: 28619758
Journal: Small GTPases. 2017 Jun 28:1-8.
Title: Co-dependency between KRAS addiction and ARHGEF2 promotes an adaptive escape from MAPK pathway inhibition.
Author: Kent, Oliver A|Sandi, Maria-Jose|Rottapel, Robert
PMID: 28656876
Journal: J Exp Clin Cancer Res. 2017 Jul 3;36(1):91.
Title: In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer.
Author: Fujita, Megumi|Hasegawa, Ai|Yamamori, Motohiro|Okamura, Noboru
PMID: 28673319
Journal: Clin Cancer Res. 2017 Oct 1;23(19):5892-5911.
Title: Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth.
Author: Li, Ming|Radvanyi, Laszlo|Yin, Bingnan|Li, Jia|Chivukula, Raghavender|Lin, Kevin|Lu, Yue|Shen, JianJun|Chang, David Z|Li, Donghui|Johanning, Gary L|Wang-Johanning, Feng
PMID: 28679769
Journal: Mol Cell Biol. 2017 Jul 10. pii: MCB.00132-17.
Title: Phosphorylation of the C-Raf N-region promotes Raf dimerization.
Author: Takahashi, Maho|Li, Yanping|Dillon, Tara J|Kariya, Yumi|Stork, Philip J S
PMID: 28694330
Journal: Biomacromolecules. 2017 Aug 14;18(8):2247-2257.
Title: Chloroquine-Modified Hydroxyethyl Starch as a Polymeric Drug for Cancer Therapy.
Author: Sleightholm, Richard|Yang, Bin|Yu, Fei|Xie, Ying|Oupicky, David
PMID: 28708385
Journal: Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017 Jul;33(7):920-925.
Title: [Expressions of stem cell factor and hypoxia inducible factor 1 alpha in pancreatic cancer cells and related mechanism].
Author: Zhang, Min|Wang, Yunjian|Li, Qiong|Li, Qingjun|Yang, Nanmu|You, Guohua|Wang, Li
PMID: 28712399
Journal: Cancer Res. 2017 Aug 15;77(16):4328-4341.
Title: Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1-MAPK Interaction.
Author: Jin, Xin|Pan, Yunqian|Wang, Liguo|Ma, Tao|Zhang, Lizhi|Tang, Amy H|Billadeau, Daniel D|Wu, Heshui|Huang, Haojie
PMID: 28720574
Journal: BMC Cancer. 2017 Jul 21;17(1):495.
Title: Expression of the scaffold connector enhancer of kinase suppressor of Ras 1 (CNKSR1) is correlated with clinical outcome in pancreatic cancer.
Author: Quadri, Humair S|Aiken, Taylor J|Allgaeuer, Michael|Moravec, Radim|Altekruse, Sean|Hussain, S Perwez|Miettinen, Markku M|Hewitt, Stephen M|Rudloff, Udo
PMID: 28732488
Journal: Int J Cancer. 2017 Nov 15;141(10):2131-2142.
Title: GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts.
Author: Bernier, Michel|Catazaro, Jonathan|Singh, Nagendra S|Wnorowski, Artur|Boguszewska-Czubara, Anna|Jozwiak, Krzysztof|Powers, Robert|Wainer, Irving W
PMID: 28741686
Journal: Cell Rep. 2017 Jul 25;20(4):999-1015.
Title: A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution.
Author: Anderson, Grace R|Winter, Peter S|Lin, Kevin H|Nussbaum, Daniel P|Cakir, Merve|Stein, Elizabeth M|Soderquist, Ryan S|Crawford, Lorin|Leeds, Jim C|Newcomb, Rachel|Stepp, Priya|Yip, Catherine|Wardell, Suzanne E|Tingley, Jennifer P|Ali, Moiez|Xu, Mengmeng|Ry
PMID: 28746882
Journal: Biochem Biophys Res Commun. 2017 Nov 4;493(1):592-597.
Title: RAGE maintains high levels of NFkappaB and oncogenic Kras activity in pancreatic cancer.
Author: Azizan, Nancy|Suter, Melissa A|Liu, Yan|Logsdon, Craig D
PMID: 28867179
Journal: J Exp Clin Cancer Res. 2017 Sep 11;36(1):124.
Title: Sophoridine induces apoptosis and S phase arrest via ROS-dependent JNK and ERK activation in human pancreatic cancer cells.
Author: Xu, Zihang|Zhang, Fei|Bai, Chao|Yao, Chao|Zhong, Hairong|Zou, Chunpu|Chen, Xiao
PMID: 28893319
Journal: J Biol Chem. 2017 Oct 27;292(43):17681-17702.
Title: The transcription factor HOXB7 regulates ERK kinase activity and thereby stimulates the motility and invasiveness of pancreatic cancer cells.
Author: Tsuboi, Makiko|Taniuchi, Keisuke|Shimizu, Takahiro|Saito, Motoaki|Saibara, Toshiji
PMID: 28912272
Journal: Oncotarget. 2017 Apr 7;8(34):56351-56363.
Title: Baicalein inhibits pancreatic cancer cell proliferation and invasion via suppression of NEDD9 expression and its downstream Akt and ERK signaling pathways.
Author: Zhou, Rong-Tao|He, Mei|Yu, Ze|Liang, Yang|Nie, Yuzhe|Tai, Sheng|Teng, Chun-Bo
PMID: 28915595
Journal: Cancer Lett. 2017 Dec 28;411:44-56.
Title: NEMO peptide inhibits the growth of pancreatic ductal adenocarcinoma by blocking NF-kappaB activation.
Author: Zhuang, Zhuonan|Li, Hao|Lee, Harold|Aguilar, Mitzi|Gocho, Takashi|Ju, Huaiqiang|Iida, Tomonori|Ling, Jianhua|Fu, Jie|Wu, Min|Sun, Yichen|Lu, Yu|Chiao, Paul J
PMID: 28951128
Journal: Ann Clin Lab Sci. 2017 Sep;47(5):572-580.
Title: Aminoguanidine (AG) Induces Induced both Pro- and Antioxidant Effect in AR42J Cells, a Rat Pancreatic Tumor Cell Line.
Author: Chowdhury, Parimal
PMID: 29066484
Journal: Oncotarget. 2017 May 11;8(42):71672-71684.
Title: Functional heterogeneity in tumor-derived human pancreatic stellate cells: Differential expression of HGF and implications for mitogenic signaling and migration in pancreatic cancer cells.
Author: Tjomsland, Vegard|Aasrum, Monica|Christoffersen, Thoralf|Gladhaug, Ivar P
PMID: 29069737
Journal: Cell Death Dis. 2017 Oct 26;8(10):e3147.
Title: Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway.
Author: Sheng, Weiwei|Chen, Chuanping|Dong, Ming|Wang, Guosen|Zhou, Jianping|Song, He|Li, Yang|Zhang, Jian|Ding, Shuangning
PMID: 29072694
Journal: J Radiat Res. 2017 Nov 1;58(6):816-826.
Title: The CD44 standard isoform contributes to radioresistance of pancreatic cancer cells.
Author: Tsubouchi, Kento|Minami, Kazumasa|Hayashi, Naoki|Yokoyama, Yuhki|Mori, Seiji|Yamamoto, Hirofumi|Koizumi, Masahiko
PMID: 29106581
Journal: Oncotarget. 2016 Aug 23;8(52):89552-89565.
Title: Role of microenvironmental periostin in pancreatic cancer progression.
Author: Liu, Yang|Li, Fan|Gao, Feng|Xing, Lingxi|Qin, Peng|Liang, Xingxin|Zhang, Jiajie|Qiao, Xiaohui|Lin, Lizhou|Zhao, Qian|Du, Lianfang
PMID: 29163770
Journal: Oncotarget. 2017 Oct 4;8(54):92667-92681.
Title: Thioredoxin system-mediated regulation of mutant Kras associated pancreatic neoplasia and cancer.
Author: Schultz, Michelle A|Diaz, Andrew M|Smite, Sharon|Lay, Anna R|DeCant, Brian|McKinney, Ronald|Mascarinas, Windel E|Xia, Yinglin|Neumann, Carola|Bentrem, David|Dawson, David W|Grippo, Paul J
PMID: 29190947
Journal: Sci Rep. 2017 Dec 11;7(1):17313.
Title: Negative regulation of TGF-beta1-induced MKK6-p38 and MEK-ERK signalling and epithelial-mesenchymal transition by Rac1b.
Author: Witte, David|Otterbein, Hannah|Forster, Maria|Giehl, Klaudia|Zeiser, Robert|Lehnert, Hendrik|Ungefroren, Hendrik
PMID: 29229918
Journal: Oncotarget. 2017 Sep 22;8(59):99693-99706.
Title: Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression.
Author: Peng, Meiyu|Zhang, Qi|Cheng, Yingnan|Fu, Shuyu|Yang, Huipeng|Guo, Xiangdong|Zhang, Jieyou|Wang, Lina|Zhang, Lijuan|Xue, Zhenyi|Li, Yan|Da, Yurong|Yao, Zhi|Qiao, Liang|Zhang, Rongxin
PMID: 29245934
Journal: Oncotarget. 2017 Oct 9;8(61):103167-103181.
Title: Cucurbitacin B and SCH772984 exhibit synergistic anti-pancreatic cancer activities by suppressing EGFR, PI3K/Akt/mTOR, STAT3 and ERK signaling.
Author: Zhou, Jingkai|Zhao, Tiangang|Ma, Linfeng|Liang, Min|Guo, Ying-Jie|Zhao, Li-Mei
PMID: 29262554
Journal: Postepy Dermatol Alergol. 2017 Oct;34(5):418-428.
Title: The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors.
Author: Owczarek, Witold|Slowinska, Monika|Lesiak, Aleksandra|Ciazynska, Magdalena|Maciag, Aldona|Paluchowska, Elwira|Marek-Jozefowicz, Luiza|Czajkowski, Rafal
PMID: 29507555
Journal: Clin Cancer Res. 2018 Jan 15;24(2):433-444.
Title: Monoclonal Antibodies Directed against Cadherin RGD Exhibit Therapeutic Activity against Melanoma and Colorectal Cancer Metastasis.
Author: Bartolome, Ruben A|Aizpurua, Carmen|Jaen, Marta|Torres, Sofia|Calvino, Eva|Imbaud, Juan I|Casal, J Ignacio
PMID: 28916526
Journal: Biochem Biophys Res Commun. 2018 Jan 1;495(1):71-77.
Title: Exosomes derived from pancreatic cancer cells induce activation and profibrogenic activities in pancreatic stellate cells.
Author: Masamune, Atsushi|Yoshida, Naoki|Hamada, Shin|Takikawa, Tetsuya|Nabeshima, Tatsuhide|Shimosegawa, Tooru
PMID: 29111329
Journal: Int J Cancer. 2018 Jun 1;142(11):2323-2334.
Title: KRAS promotes tumor metastasis and chemoresistance by repressing RKIP via the MAPK-ERK pathway in pancreatic cancer.
Author: Yang, Kege|Li, Yaqing|Lian, Guoda|Lin, Haoming|Shang, Changzhen|Zeng, Linjuan|Chen, Shaojie|Li, Jiajia|Huang, Chumei|Huang, Kaihong|Chen, Yinting
PMID: 29315556
Journal: Mol Cell Proteomics. 2018 Apr;17(4):655-671.
Title: Temporal Effects of Combined Birinapant and Paclitaxel on Pancreatic Cancer Cells Investigated via Large-Scale, Ion-Current-Based Quantitative Proteomics (IonStar).
Author: Wang, Xue|Niu, Jin|Li, Jun|Shen, Xiaomeng|Shen, Shichen|Straubinger, Robert M|Qu, Jun
PMID: 29358341
Journal: J Cell Commun Signal. 2018 Jan 29. pii: 10.1007/s12079-017-0444-0.
Title: p38 differentially regulates ERK, p21, and mitogenic signalling in two pancreatic carcinoma cell lines.
Author: Aasrum, Monica|Thoresen, G Hege|Christoffersen, Thoralf|Brusevold, Ingvild J
PMID: 29380233
Journal: J Biol Chem. 2018 Mar 23;293(12):4334-4349.
Title: The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.
Author: Maity, Gargi|Haque, Inamul|Ghosh, Arnab|Dhar, Gopal|Gupta, Vijayalaxmi|Sarkar, Sandipto|Azeem, Imaan|McGregor, Douglas|Choudhary, Abhishek|Campbell, Donald R|Kambhampati, Suman|Banerjee, Sushanta K|Banerjee, Snigdha
PMID: 29414775
Journal: Oncotarget. 2017 Dec 25;9(4):5274-5286.
Title: Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer.
Author: Awasthi, Niranjan|Monahan, Sheena|Stefaniak, Alexis|Schwarz, Margaret A|Schwarz, Roderich E
PMID: 29435178
Journal: Int J Oncol. 2018 Apr;52(4):1105-1116.
Title: RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling.
Author: Qi, Zi-Hao|Xu, Hua-Xiang|Zhang, Shi-Rong|Xu, Jin-Zhi|Li, Shuo|Gao, He-Li|Jin, Wei|Wang, Wen-Quan|Wu, Chun-Tao|Ni, Quan-Xing|Yu, Xian-Jun|Liu, Liang
PMID: 29436617
Journal: Anal Biochem. 2018 May 1;548:44-52.
Title: High-throughput screening identifies small molecules that bind to the RAS:SOS:RAS complex and perturb RAS signaling.
Author: Burns, Michael C|Howes, Jennifer E|Sun, Qi|Little, Andrew J|Camper, DeMarco V|Abbott, Jason R|Phan, Jason|Lee, Taekyu|Waterson, Alex G|Rossanese, Olivia W|Fesik, Stephen W
PMID: 29444450
Journal: Oncotarget. 2018 Jan 8;9(6):6938-6951.
Title: Spiclomazine displays a preferential anti-tumor activity in mutant KRas-driven pancreatic cancer.
Author: Guo, Xiaoyu|Zhao, Wenjing|Liu, Zuojia|Wang, Jin
PMID: 29467941
Journal: Cell Signal. 2018 Jul;47:101-108.
Title: alpha-cyano-4-hydroxycinnamate impairs pancreatic cancer cells by stimulating the p38 signaling pathway.
Author: Schonrogge, Maria|Kerndl, Hagen|Zhang, Xianbin|Kumstel, Simone|Vollmar, Brigitte|Zechner, Dietmar
PMID: 29609037
Journal: Mol Carcinog. 2018 Sep;57(9):1130-1143.
Title: A novel tricarbonylmethane agent (CMC2.24) reduces human pancreatic tumor growth in mice by targeting Ras.
Author: Mallangada, Naveen A|Vargas, Joselin M|Thomas, Swaroopa|DiGiovanni, Matthew G|Vaeth, Brandon M|Nemesure, Matthew D|Wang, Ruixue|LaComb, Joseph F|Williams, Jennie L|Golub, Lorne M|Johnson, Francis|Mackenzie, Gerardo G
PMID: 29683208
Journal: Biochem Biophys Res Commun. 2018 Jun 12;500(4):873-878.
Title: ROS mediated EGFR/MEK/ERK/HIF-1alpha Loop Regulates Glucose metabolism in pancreatic cancer.
Author: Wang, Gang|Li, Yifeng|Yang, Zeyu|Xu, Weina|Yang, Yifan|Tan, Xiaodong
PMID: 29702094
Journal: Cancer Lett. 2018 Sep 28;432:237-250.
Title: Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer.
Author: Li, Zhonghu|Yanfang, Wu|Li, Jie|Jiang, Peng|Peng, Tao|Chen, Kai|Zhao, Xin|Zhang, Yujun|Zhen, Ping|Zhu, Jin|Li, Xiaowu
PMID: 29709702
Journal: Int J Oncol. 2018 Jul;53(1):349-357.
Title: Inhibition of interleukin 8/CX-C chemokine receptor 1,/2 signaling reduces malignant features in human pancreatic cancer cells.
Author: Fu, Shengling|Chen, Xiang|Lin, Huey-Jen|Lin, Jiayuh
PMID: 29749433
Journal: Cancers (Basel). 2018 May 14;10(5). pii: cancers10050142.
Title: A New Strategy to Control and Eradicate "Undruggable" Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology.
Author: Van Sciver, Robert E|Lee, Michael P|Lee, Caroline Dasom|Lafever, Alex C|Svyatova, Elizaveta|Kanda, Kevin|Colliver, Amber L|Siewertsz van Reesema, Lauren L|Tang-Tan, Angela M|Zheleva, Vasilena|Bwayi, Monicah N|Bian, Minglei|Schmidt, Rebecca L|Matrisian, Ly
PMID: 29757973
Journal: Pol Przegl Chir. 2018 Apr 30;90(2):45-53.
Title: Surgical treatment of pancreatic cancer.
Author: Masiak-Segit, Wioletta|Rawicz-Pruszynski, Karol|Skorzewska, Magdalena|Polkowski, Wojciech P
PMID: 29773761
Journal: Biochim Biophys Acta Mol Basis Dis. 2018 Aug;1864(8):2538-2549.
Title: Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-beta1/FAK/ERK pathway.
Author: Jahan, Rahat|Macha, Muzafar A|Rachagani, Satyanarayana|Das, Srustidhar|Smith, Lynette M|Kaur, Sukhwinder|Batra, Surinder K
PMID: 29777904
Journal: Nat Commun. 2018 May 25;9(1):2081.
Title: In vivo reprogramming drives Kras-induced cancer development.
Author: Shibata, Hirofumi|Komura, Shingo|Yamada, Yosuke|Sankoda, Nao|Tanaka, Akito|Ukai, Tomoyo|Kabata, Mio|Sakurai, Satoko|Kuze, Bunya|Woltjen, Knut|Haga, Hironori|Ito, Yatsuji|Kawaguchi, Yoshiya|Yamamoto, Takuya|Yamada, Yasuhiro
PMID: 29802314
Journal: Theranostics. 2018 Apr 30;8(11):3074-3086.
Title: MMP1/PAR1/SP/NK1R paracrine loop modulates early perineural invasion of pancreatic cancer cells.
Author: Huang, Chumei|Li, Yaqing|Guo, Yubo|Zhang, Zuoquan|Lian, Guoda|Chen, Yinting|Li, Jian|Su, Yonghui|Li, Jiajia|Yang, Kege|Chen, Shaojie|Su, Hong|Huang, Kaihong|Zeng, Linjuan
PMID: 29896303
Journal: Cancer Lett. 2018 Oct 1;433:76-85.
Title: Loss of Linc01060 induces pancreatic cancer progression through vinculin-mediated focal adhesion turnover.
Author: Shi, Xiuhui|Guo, Xingjun|Li, Xu|Wang, Min|Qin, Renyi
PMID: 29913236
Journal: Theranostics. 2018 May 23;8(12):3366-3379.
Title: Functional role of BTB and CNC Homology 1 gene in pancreatic cancer and its association with survival in patients treated with gemcitabine.
Author: Huang, Xudong|Zheng, Jian|Li, Jun|Che, Xu|Tan, Wenle|Tan, Wen|Shao, Mingming|Cheng, Xinxin|Du, Zhongli|Zhao, Yanjie|Wang, Chengfeng|Wu, Chen|Lin, Dongxin
PMID: 29930735
Journal: Yonsei Med J. 2018 Aug;59(6):727-735.
Title: Synergistic Anti-Cancer Effects of AKT and SRC Inhibition in Human Pancreatic Cancer Cells.
Author: Ahn, Kang|O, Young Moon|Ji, Young Geon|Cho, Han Jun|Lee, Dong Hyeon
PMID: 29978609
Journal: Int J Mol Sci. 2018 Jul 9;19(7). pii: ijms19072004.
Title: A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model.
Author: Wu, Guang|Maharjan, Sony|Kim, Dongbum|Kim, Jung Nam|Park, Byoung Kwon|Koh, Heeju|Moon, Kyungduk|Lee, Younghee|Kwon, Hyung-Joo
PMID: 29987260
Journal: Endocr Relat Cancer. 2018 Jul 18. pii: ERC-18-0222.
Title: The IGF pathway is activated in insulinomas but downregulated in metastatic disease.
Author: Henfling, Mieke|Perren, Aurel|Schmitt, Anja Maria|Saddig, Christiane M|Starke, Achim A|Riedl, Robert G|Versleijen-Jonkers, Yvonne M H|Sprij-Mooij, Diane M|Ramaekers, Frans C S|Hofland, Leo|Speel, Ernst-Jan M
PMID: 30021864
Journal: Immunohorizons. 2018 Apr 1;2(4):107-118.
Title: Diacylglycerol kinase zeta (DGKzeta) and Casitas b-lineage proto-oncogene b-deficient mice have similar functional outcomes in T cells but DGKzeta-deficient mice have increased T cell activation and tumor clearance.
Author: Wesley, Erin M|Xin, Gang|McAllister, Donna|Malarkannan, Subramaniam|Newman, Debra K|Dwinell, Michael B|Cui, Weiguo|Johnson, Bryon D|Riese, Matthew J
PMID: 30027154
Journal: Cell Death Dis. 2018 Jul 23;9(8):804.
Title: Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis.
Author: Akimoto, Miho|Maruyama, Riruke|Kawabata, Yasunari|Tajima, Yoshitsugu|Takenaga, Keizo
PMID: 30038429
Journal: J Exp Clin Cancer Res. 2018 Jul 24;37(1):166.
Title: Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer.
Author: Sun, Yan|Peng, Wenfang|He, Weiwei|Luo, Man|Chang, Guilin|Shen, Jiping|Zhao, Xiaoping|Hu, Yu
PMID: 30041673
Journal: Cell Death Dis. 2018 Jul 24;9(8):807.
Title: MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma.
Author: Hu, Jisheng|Li, Le|Chen, Hongze|Zhang, Guangquan|Liu, Huan|Kong, Rui|Chen, Hua|Wang, Yongwei|Li, Yilong|Tian, Fengyu|Lv, Xinjian|Li, Guanqun|Sun, Bei
PMID: 30042387
Journal: Pancreatology. 2018 Sep;18(6):678-688.
Title: Knockdown of AGR2 induces cell apoptosis and reduces chemotherapy resistance of pancreatic cancer cells with the involvement of ERK/AKT axis.
Author: Liu, Qing-Guo|Li, Yan-Ju|Yao, Lan
PMID: 30055941
Journal: Mol Cancer Ther. 2018 Jul 31. pii: 1535-7163.MCT-17-1142.
Title: Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models.
Author: Jiang, Hongmei|Xu, Mai|Li, Lin|Grierson, Patrick|Dodhiawala, Paarth|Highkin, Maureen|Zhang, Daoxiang|Li, Qiong|Wang-Gillam, Andrea|Lim, Kian-Huat
PMID: 30065098
Journal: Cancer Biol Ther. 2018 Aug 24:1-13.
Title: Prior exposure of pancreatic tumors to [sorafenib + vorinostat] enhances the efficacy of an anti-PD-1 antibody.
Author: Booth, Laurence|Roberts, Jane Lisa|Poklepovic, Andrew|Dent, Paul
PMID: 30142009
Journal: Cancer Res. 2018 Aug 28. pii: 0008-5472.CAN-18-0634.
Title: Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
Author: Nagathihalli, Nagaraj S|Castellanos, Jason|Lamichhane, Purushottam|Messaggio, Fanuel|Shi, Chanjuan|Dai, Xizi|Rai, Priyamvada|Chen, Xi|VanSaun, Michael N|Merchant, Nipun B
PMID: 30154150
Journal: J Exp Clin Cancer Res. 2018 Sep 10;37(1):224.
Title: FBP1 loss contributes to BET inhibitors resistance by undermining c-Myc expression in pancreatic ductal adenocarcinoma.
Author: Wang, Bo|Fan, Ping|Zhao, Jingyuan|Wu, Heyu|Jin, Xin|Wu, Heshui
PMID: 30201002
Journal: Pancreatology. 2018 Aug 24. pii: S1424-3903(18)30645-8.
Title: The radiotherapy-sensitization effect of cantharidin: Mechanisms involving cell cycle regulation, enhanced DNA damage, and inhibited DNA damage repair.
Author: Xu, Meng-Dan|Liu, Shu-Ling|Zheng, Bei-Bei|Wu, Jing|Wu, Meng-Yao|Zhang, Yan|Gong, Fei-Ran|Tao, Min|Zhang, Junning|Li, Wei
PMID: 30201439
Journal: Cancer Lett. 2018 Sep 11;438:174-186.
Title: KRAS targeting antibody synergizes anti-cancer activity of gemcitabine against pancreatic cancer.
Author: Kang, Yeo Wool|Lee, Ji Eun|Jung, Kyung Hee|Son, Mi Kwon|Shin, Seung-Min|Kim, Soo Jung|Fang, Zhenghuan|Yan, Hong Hua|Park, Jung Hee|Han, Boreum|Cheon, Min Ji|Woo, Min Gyu|Lim, Joo Han|Kim, Yong-Sung|Hong, Soon-Sun
PMID: 30217561
Journal: Oncol Rep. 2018 Nov;40(5):3102-3111.
Title: Tanshinone IIA can inhibit MiaPaCa2 human pancreatic cancer cells by dual blockade of the Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways.
Author: Su, Chin-Cheng
PMID: 30226540
Journal: Mol Ther Nucleic Acids. 2018 Aug 22;13:121-132.
Title: miR-7 Suppresses Tumor Progression by Directly Targeting MAP3K9 in Pancreatic Cancer.
Author: Xia, Jun|Cao, Tong|Ma, Cong|Shi, Ying|Sun, Yu|Wang, Z Peter|Ma, Jia
PMID: 30290304
Journal: Mol Cell Biochem. 2018 Oct 11. pii: 10.1007/s11010-018-3455-0.
Title: C6orf106 accelerates pancreatic cancer cell invasion and proliferation via activating ERK signaling pathway.
Author: Li, Xin|Dong, Ming|Zhou, Jianping|Zhu, Dehua|Zhao, Jinbo|Sheng, Weiwei
PMID: 30311108
Journal: Cancer Res. 2018 Oct 24. pii: 0008-5472.CAN-18-1968.
Title: PIN1 maintains redox balance via the c-Myc/NRF2 axis to counteract Kras-induced mitochondrial respiratory injury in pancreatic cancer cells.
Author: Liang, Chen|Shi, Si|Liu, Mingyang|Qin, Yi|Meng, Qingcai|Hua, Jie|Ji, Shunrong|Zhang, Yuqing|Yang, Jingxuan|Xu, Jin|Ni, Quanxing|Li, Min|Yu, Xianjun
PMID: 30355620